0001214659-23-007724 10-Q 44 20230331 20230523 20230523 Ault Disruptive Technologies Corp 0001864032 6770 862279256 DE 1231 10-Q 34 001-41171 23948415 11411 SOUTHERN HIGHLANDS PKWY 240 LAS VEGAS NV 89141 (949) 444-5464 11411 SOUTHERN HIGHLANDS PKWY 240 LAS VEGAS NV 89141 10-Q 1 g5523010q.htm
0001864032 false --12-31 2023 Q1 0001864032 2023-01-01 2023-03-31 0001864032 adrt:UnitsEachConsistingOfOneShareOfcommonStockParValue0.001PerShareandThreefourthsOfOneRedeemableWarrantToPurchaseOneShareOfCommonStockMember 2023-01-01 2023-03-31 0001864032 adrt:CommonStock0.001ParValueMember 2023-01-01 2023-03-31 0001864032 2023-05-22 0001864032 2023-03-31 0001864032 2022-12-31 0001864032 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2022-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001864032 us-gaap:RetainedEarningsMember 2022-12-31 0001864032 us-gaap:CommonStockMember 2021-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001864032 us-gaap:RetainedEarningsMember 2021-12-31 0001864032 2021-12-31 0001864032 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001864032 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001864032 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2023-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001864032 us-gaap:RetainedEarningsMember 2023-03-31 0001864032 us-gaap:CommonStockMember 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-03-31 0001864032 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-13 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2023-03-31 0001864032 us-gaap:OverAllotmentOptionMember 2023-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-19 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-18 2021-12-20 0001864032 adrt:LiquidationMember 2023-03-31 0001864032 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-01-01 2023-03-31 0001864032 adrt:NonRedeemableCommonStockMember 2023-01-01 2023-03-31 0001864032 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2022-01-01 2022-03-31 0001864032 adrt:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 adrt:SponsorMember 2021-02-22 2021-02-23 0001864032 us-gaap:CommonStockMember 2021-02-23 0001864032 2021-02-23 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001864032 adrt:SponsorMember adrt:PrivatePlacement1Member 2023-01-01 2023-03-31 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2023-03-31 0001864032 adrt:AdministrativeServicesAgreementMember 2023-01-01 2023-03-31 0001864032 adrt:AdministrativeServicesAgreementMember 2022-01-01 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember us-gaap:IPOMember 2021-12-20 0001864032 adrt:FounderSharesMember 2021-02-23 0001864032 us-gaap:PrivatePlacementMember srt:MinimumMember 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel3Member 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

  (Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-41171

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 86-2279256
(State or other jurisdiction of incorporation or organization)  (I.R.S. Employer Identification Number)

 

11411 Southern Highlands Pkwy, Suite 240,

Las Vegas, NV

89141 (949) 444-5464
(Address of principal executive offices) (Zip Code) (Registrant’s telephone number, including area code)

 

Securities registered under Section 12(b) of the Act:

 

Title of each class  Trading
Symbol(s)
  Name of each exchange on which registered
Units, each consisting of one share of Common Stock, par value $0.001 per share and three-fourths of one Redeemable Warrant to purchase one share of Common Stock  ADRU  NYSE American
Common Stock, $0.001 par value  ADRT  NYSE American

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x   No  ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated Filer x Smaller reporting company x
    Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes x    No  ¨

 

As of May 23, 2023, there were 14,375,000 outstanding shares of the registrant’s common stock, $0.001 par value per share, of which 11,500,000 shares are subject to possible redemption.
 

 

  
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

Quarterly Report on Form 10-Q

Table of Contents

 

PART I. FINANCIAL INFORMATION 1
     
Item 1. Financial Statements 1
     
  Condensed Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022 1
     
  Unaudited Condensed Statements of Operations for the Three Months Ended March 31, 2023 and 2022 2
     
  Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the Three Months Ended March 31, 2023 and 2022 3
     
  Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022 4
     
  Notes to Unaudited Condensed Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 22
     
Item 4. Controls and Procedures 22
   
PART II. OTHER INFORMATION 23
     
Item 1. Legal Proceedings 23
     
Item 1A. Risk Factors 23
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
Item 3. Defaults Upon Senior Securities 23
     
Item 4. Mine Safety Disclosures 23
     
Item 5. Other Information 23
     
Item 6. Exhibits 24
     
SIGNATURES 25

 

  
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

CONDENSED BALANCE SHEETS

 

         
   March 31, 2023   December 31, 2022 
   (Unaudited)     
Assets        
Current asset - cash  $63,161   $206,527 
Prepaid expenses   304,457    391,443 

Cash and marketable securities held in Trust Account

   119,254,187    118,193,123 
Total current assets   119,621,805    118,791,093 
Prepaid expenses, noncurrent   -    10,873 
Deferred tax asset, noncurrent   27,062    27,062 
Total Assets  $119,648,867   $118,829,028 
Liabilities and Stockholders’ Deficit          
Current liabilities:          
Accounts payable  $136,276   $60,952 
Accrued franchise taxes   50,000    200,000 
Income tax payable   623,846    285,003 

Common stock subject to possible redemption, 11,500,000 shares at redemption value(1)

   118,672,204    117,800,181 
Total current liabilities   119,482,326    118,346,136 
Deferred underwriting commissions   3,450,000    3,450,000 
Total liabilities   122,932,326    121,796,136 
           
Stockholders’ Deficit:          
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding   -    - 
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding   2,875    2,875 
Additional paid-in capital   -    - 
Accumulated deficit   (3,286,334)   (2,969,983)
Total stockholders’ deficit   (3,283,459)   (2,967,108)
Total Liabilities and Stockholders’ Deficit  $119,648,867   $118,829,028 
(1)The common stock redemption value is net of amounts eligible to be withdrawn from the Trust Account to pay franchise and income taxes.

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 1 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

 

           
   For the Three Months Ended March 31, 
   2023   2022 
Operating costs  $358,888   $296,891 
Loss from operations   (358,888)   (296,891)
Other income:          
Income from investments held in trust account   1,253,403    11,754 
Interest expense, net   -    (3,063)
Total other income   1,253,403    8,691 
Net income (loss) before income taxes   894,515    (288,200)
Provision for income taxes   338,843    - 
Net income (loss)  $555,672   $(288,200)
           
Basic and diluted weighted average shares outstanding, common stock subject to redemption   11,500,000    11,500,000 
Basic and diluted net income (loss) per share attributable to common stock subject to redemption  $0.04   $(0.02)
Basic and diluted weighted average shares outstanding, common stock   2,875,000    2,875,000 
Basic and diluted net income (loss) per share attributable to common stockholders  $0.04   $(0.02)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 2 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

 

 

Three Months Ended March 31, 2023

 

                          
   Common
Stock
Shares
   Common
Stock
Amount
   Additional
Paid-in
Capital
   Accumulated
Deficit
   Total
Stockholders’
Deficit
 
Balance, January 1, 2023   2,875,000   $2,875   $-   $(2,969,983)  $(2,967,108)
Remeasurement adjustment on redeemable common stock, net(1)   -    -    -    (872,023)   (872,023)
Net income   -    -    -    555,672    555,672 
Balance, March 31, 2023   2,875,000   $2,875   $-   $(3,286,334)  $(3,283,459)
(1)Remeasurement adjustment is net of amounts eligible to be withdrawn from the Trust Account to pay franchise and income taxes for the period.

 

 

Three Months Ended March 31, 2022

 

   Common
Stock
Shares
   Common
Stock
Amount
   Additional
Paid-in
Capital
   Accumulated
Deficit
   Total
Stockholders’
Deficit
 
Balance, January 1, 2022   2,875,000   $2,875   $-   $(1,766,410)  $(1,763,535)
Net loss   -    -    -    (288,200)   (288,200)
Balance, March 31, 2022   2,875,000   $2,875   $-   $(2,054,610)  $(2,051,735)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

 

           
   For the Three Months Ended March 31, 
   2023   2022 
Cash Flows from Operating Activities:        
Net income (loss)  $555,672   $(288,200)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Income from investments held in Trust Account   (1,253,403)   (11,754)
Changes in current assets and current liabilities:          
Prepaid expenses   97,859    56,601 
Accounts payable   75,324    - 
Accrued expenses   -    (346,067)
Tax payable   188,843   - 
Net cash used in operating activities   (335,705)   (589,420)
Cash Flows from Investing Activities:          
Sale of investment held in Trust Account   192,339    - 
Net cash provided by investing activities   192,339    - 
Cash Flows from Financing Activities:          
Payments of offering costs   -    (150,636)
Net cash used in financing activities   -    (150,636)
           
Net change in cash   (143,366)   (740,056)
Cash, beginning of the period   206,527    1,849,679 
Cash, end of the period  $63,161   $1,109,623 
           
Supplemental disclosure of noncash investing and financing activities:          
Remeasurement of common stock subject to possible redemption  $872,023   $- 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 
 

 

AULT DISRUPTIVE TECHNOLOGIES CORPORATION

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 1 — Organization and Business Operations

 

Organization

 

Ault Disruptive Technologies Corporation (the “Company” or “We”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.

 

As of March 31, 2023, the Company had not commenced any operations. All activity for the period from February 22, 2021 (“Inception”) through March 31, 2023, relates to the Company’s formation, the Initial Public Offering (“IPO” or “Public Offering”) described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate nonoperating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.

 

The Company’s Sponsor is Ault Disruptive Technologies Company, LLC, a Delaware limited liability company that is a wholly owned subsidiary of Ault Alliance, Inc., a Delaware corporation (NYSE American: AULT) (the “Sponsor”).

 

Financing 

 

The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 6,500,000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

Transaction costs related to the IPO amounted to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions, and $784,000 of other offering costs. In addition, $1,849,679 of cash was held outside of the Trust Account (as defined below) and used for working capital purposes.

 

 5 
 

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

Trust Account

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company's initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company's initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company's public shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 18 months following the effectiveness of the Public Offering, the Company's return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company's public stockholders may receive only approximately $10.35 per public share on the liquidation of the Company's trust account and its warrants will expire worthlessly.

 

The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

 

The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $10.35 per public share.

 

 6 
 

 

The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. 

 

The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 18 months following the effectiveness of the Public Offering (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

 

The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 7), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.35 per Public Share). 

 

 7 
 

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.35 per public share, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Going Concern

 

As of March 31, 2023, the Company had $63,161 in its operating bank account and working capital of $813,325, exclusive of taxes payable.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any.

 

The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. As of March 31, 2023, the Company has been unable to consummate its initial business combination, and it is uncertain that it will be able to consummate a business combination prior to our second extension deadline of June 20, 2023.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management continues to seek to complete a Business Combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 20, 2023. The accompanying unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

 

 8 
 

 

Risks and Uncertainties

 

The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. 

 

Management continues to evaluate the impact of the COVID-19 pandemic on the industry and currently believes that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

In February 2022, a military conflict started between Russia and Ukraine. The ongoing military conflict between Russia and Ukraine has provoked strong reactions from the United States, the United Kingdom, the European Union and various other countries around the world, including the imposition of broad financial and economic sanctions against Russia. Further, the precise effects of the ongoing military conflict and these sanctions on the global economies remain uncertain as of the date of the accompanying unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of the accompanying unaudited condensed financial statements.

 

Inflation Reduction Act

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

 

The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods.

 

 9 
 

 

Note 2 — Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected in the future.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 4, 2023.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  

 

Use of Estimates

 

The preparation of the financial statements is in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Accounting Policy on Redeemable Shares

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times shares of common stock will be classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of certain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.

 

 10 
 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero. 

 

As of March 31, 2023, Common Stock subject to possible redemption reflected in the unaudited condensed balance sheets are reconciled in the following table:

 

     
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to Common Stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   13,979,594 
Common Stock subject to possible redemption as of December 31, 2022   117,800,181 
Remeasurement of Common Stock subject to possible redemption   872,023 
Common Stock subject to possible redemption as of March 31, 2023  $118,672,204 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.

 

Marketable Securities Held in Trust Account

 

As of March 31, 2023 and December 31, 2022, the Company held $119,254,187 and $118,193,123, respectively, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2023, the Company withdrew $192,339 of dividend income from the Trust Account to pay its tax obligations.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to stockholders’ deficit. The Company incurred offering costs amounting to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions and $784,000 of other offering costs.

 

 11 
 

 

Warrant Instruments

 

The Company has accounted for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

 

Net Income (Loss) per Share of Common Stock

 

We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2023 and 2022 we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 

        
   For the Three Months Ended March 31, 2023 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net income per common share        
Numerator:        
Allocation of net income  $444,538   $111,134 
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net income per common share  $0.04   $0.04 

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

           
   For the Three Months Ended March 31, 2022 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net loss per common share        
Numerator:        
Allocation of net loss  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
 Basic and diluted net loss per common share  $(0.02)  $(0.02)

 

 12 
 

 

Income Taxes

 

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting, and ASC Topic 740, Income Taxes (“ASC 740”). The Company’s effective tax rate (“ETR”) from continuing operations was (38%) and (0%) for the three months ended March 31, 2023 and 2022, respectively. The Company recorded income tax expense of $338,843, and $0 for the three months ended March 31, 2023 and 2022, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to a U.S. federal valuation allowance.

 

A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. For the three months ended March 31, 2023 and 2022, the valuation allowance was $692,085 and $0, respectively.

 

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it had no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense. 

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

 

Note 3 — Initial Public Offering

 

On December 20, 2021, the Company consummated its IPO of 10,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 ($10.15 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. 

 

Note 4 — Private Placement Warrants

 

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 6,500,000 Private Placement Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one share of Common Stock at $11.50 per share, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

 13 
 

 

The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).

 

If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2023 or 2022.

 

Private Placement Warrants

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants, except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering.

 

Administrative Services Agreement

 

The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $10,000 per month for these services. The Company incurred $30,000 in operating cost associated with the administrative service fees for each of the three months ended March 31, 2023 and 2022.

 

Note 6 — Commitments and Contingencies

 

In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. 

 

Initial Business Combination Period Extension

 

On December 13, 2022, the Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “First Deposit”). The First Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the initial deadline of December 20, 2022, until March 20, 2023. When the Sponsor makes the First Deposit, it will receive 1,150,000 private placement warrants in connection with the First Deposit, however, this deposit has yet to be made.

 

 14 
 

 

On March 15, 2023, the Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “Second Deposit”). The Second Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the first extension deadline of March 20, 2023, until June 20, 2023. When the Sponsor makes the Second Deposit, it will receive 1,150,000 private placement warrants in connection with the Second Deposit, however, this deposit has yet to be made.

 

Registration and Shareholder Rights

 

The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common Stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. 

 

Underwriting Agreement

 

The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. 

 

The underwriters were paid at the closing of the IPO an underwriting commission of $0.25 per Unit sold in the IPO or $2,513,333. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $2,888,333 in underwriting commissions related to the IPO and over-allotment.

 

In addition, $3,000,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $3,450,000 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 

 

Note 7 — Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and 2022, there were no preferred shares issued or outstanding. 

 

 15 
 

 

Common Stock

 

The Company is authorized to issue 100,000,000 shares of Common Stock with a par value of $0.001 per share. As of March 31, 2023 and 2022, there were 2,875,000 shares of Common Stock outstanding, excluding 11,500,000 shares of Common Stock subject to possible redemption issued.

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2022 or 2023.

 

Public Warrants and Private Placement Warrants

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.

 

The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

 

If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

 16 
 

 

at a price of $0.01 per warrant;

 

upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and

 

if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.

 

If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 18 months following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 18-month period. However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 18-month period. 

 

All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.

 

 17 
 

 

Note 8 Fair Value Measurements

 

Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

                
   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2023   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $119,254,187   $119,254,187   $-   $- 
Total  $119,254,187   $119,254,187   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $118,193,123   $118,193,123   $-   $- 
Total  $118,193,123   $118,193,123   $-   $- 

 

There were no transfers between Levels 1, 2 or 3 for the period from Inception through March 31, 2023.

 

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

 18 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “Ault Disruptive Technologies Corporation “our,” “us” or “we” refer to Ault Disruptive Technologies Corporation. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

 

Overview

 

We are a newly-organized blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination throughout this Quarterly Report. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we are focused on opportunities to acquire companies with innovative and emerging technologies, products or services that have the potential to transform major industries and radically impact society. We intend to acquire a target business or businesses with disruptive technologies that our management team believes can achieve mainstream adoption and create opportunities for long-term appreciation in value. We have not selected any specific business combination target, although we have engaged in substantive discussions, directly and indirectly, with a significant number of business combination targets with respect to an initial business combination with us.

 

We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering and the sale of the Placement Warrants, the proceeds of the sale of our shares in connection with our initial business combination (including pursuant to backstop agreements we may enter into), shares issued to the owners of the target, debt issued to a bank or other lenders or the owners of the target, or a combination of the foregoing.

 

We are not prohibited from pursuing an initial Business Combination with a business that is owned by Ault Disruptive Technologies Company, LLC (the “Sponsor”) or any of the related companies or making the acquisition through a joint venture or other form of shared ownership with any of them.

 

We cannot assure you that our plans to complete our initial Business Combination will be successful.

 

Results of Operations

 

Our entire activity since February 22, 2021 (“Inception”) through March 31, 2023, relates to our formation, the IPO and since the closing of the IPO, a search for a Business Combination candidate. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

 

For the three months ended March 31, 2023, and 2022, we had net income of $555,672, compared to a net loss of $288,200, respectively. Net income for the three months ended March 31, 2023, consisted of $1,253,403 in interest earned on marketable securities held in the Trust Account, offset by $358,888 in operating costs and $338,843 of income tax expense. Net loss for the three months ended March 31, 2022, consisted of $296,891 in formation and operating costs and $3,063 of interest expense associated with our financing of our directors and officer’s insurance policy, offset by $11,754 in interest earned on marketable securities held in the Trust Account.

 

 19 
 

 

Liquidity and Capital Resources

 

As of March 31, 2023, we had $63,161 in our operating bank account, and working capital of $813,325, exclusive of taxes payable.

 

Prior to the completion of the IPO, our liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000, to cover certain offering costs, for the founder shares, and the loan under an unsecured promissory note from the Sponsor of $1,500,000. Subsequent to the consummation of the IPO and Private Placement, our liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust Account.

 

In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us with funds as may be required (“Working Capital Loans”). To date, there were no Working Capital Loans.

 

We may need to raise additional capital through loans or additional investments from our Sponsor, stockholders, officers, directors, or third parties. Our officers, directors and our Sponsor may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. We will provide our public stockholders with the opportunity to redeem all or a portion of their shares of our Common Stock upon the consummation of our initial Business Combination, subject to the limitations described herein. In addition, as we were unable to consummate our initial Business Combination within 12 months following the effectiveness of the IPO, which was December 20, 2021. Subject to the first and second deposits being made, we can extend the period of time to complete an initial Business Combination by two three month periods for a total of 18 months. If we do not complete the initial Business Combination by the end of the second extension period, we will be required to cease all operations except for the purpose of winding up. These conditions raise substantial doubt about our ability to continue as a going concern for the remainder of the extended period. The financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

 

JOBS Act

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. 

 

 20 
 

 

Critical Accounting Policies and Estimates

 

Management’s discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited condensed financial information. We describe our significant accounting policies in Note 2 – Summary of Significant Accounting Policies, within the Notes to these unaudited condensed financial statements included in this report on Form 10-Q. Our unaudited condensed financial statements have been prepared in accordance with U.S. GAAP. Certain of our accounting policies require that management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with U.S. GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.

 

We have identified the following as our critical accounting policies:

 

Accounting Policy on Redeemable Shares

 

We account for our Common Stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) will be classified as temporary equity. At all other times shares of Common Stock will be classified as stockholders’ equity. Our Common Stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.

 

We recognize changes in redemption value immediately as they occur and adjust the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero.

 

Net Income (Loss) per Share of Common Stock

 

We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of Common Stock outstanding during the period, excluding Common Stock subject to forfeiture. Remeasurement associated with the redeemable shares of Common Stock is excluded from net income (loss) per share as the redemption value approximates fair value. At March 31, 2023, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of Common Stock and then share in our earnings. As a result, diluted income per share is the same as basic income per share for the period presented.

 

Warrant Instruments

 

We accounted for the 8,625,000 Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to our Common Stock and whether the holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification.

 

 21 
 

 

Accounting Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable for a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective due to a material weakness in our internal control over financial reporting related to applying complex accounting principles relating to the analysis of financial instruments for proper classification in the financial statements, in a timely manner. We do not have sufficient resources in our accounting department, which restricts our ability to gather, analyze and properly review information related to financial reporting, including applying complex accounting principles relating to analysis of financial instruments for proper classification in the financial statements, in a timely manner. As a result, we performed additional analysis as deemed necessary to ensure that our unaudited condensed financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the unaudited condensed financial statements included in this Form 10-Q present fairly, in all material respects, our financial position, result of operations and cash flows of the periods presented.

 

Management has started implementing remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we have began to expand and improve our review process for applying complex accounting principles relating to analysis of financial instruments for proper classification in the financial statements in a timely manner. We plan to improve this process by enhancing access to accounting literature and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes to our internal control over financial reporting that occurred during our fiscal quarter ended March 31, 2023, that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

 22 
 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

 

Item 1A. Risk Factors.

 

As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Use of Proceeds

 

On December 20, 2021, we sold 11,500,000 units, including 1,500,000 units pursuant to the exercise of the underwriters’ over-allotment option in full, at a purchase price of $10.00 per unit in our IPO. Simultaneously with the closing of the IPO, we consummated the private placement of 7,100,000 private warrants for an aggregate purchase price of $7,100,000 (the “Private Placement”). Following the closing of the IPO and the Private Placement on December 20, 2021, $116,725,000 from the net proceeds of the sale of the units in the IPO and the sale of the private placement units was deposited into our trust account (the “Trust Account”), and $1,849,679 of cash was held outside of the Trust Account and is available for the Company’s working capital purposes. Transaction costs amounted to $7,087,891 in transaction costs, including $6,338,333 of underwriting fees ($3,450,000 consisted of deferred underwriting fees) and $749,558 of other costs.

 

The net proceeds deposited into the Trust Account are invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.

 

There has been no material change in the planned use of the proceeds from the IPO and Private Placement as is described in our final prospectus dated December 15, 2021 and filed with the SEC on December 16, 2021.

 

Item 3.Defaults Upon Senior Securities.

 

None.

 

Item 4.Mine Safety Disclosures.

 

Not Applicable.

 

Item 5.Other Information.

 

Not Applicable.

 

 23 
 

 

Item 6.Exhibits.

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit   Description
     
3.1   Certification of Incorporation. Incorporated herein by reference to the Registration Statement on Form S-1 filed on November 5, 2021, as Exhibit 3.1 thereto.  
     
3.2    Amended and Restated Certificate of Incorporation. Incorporated herein by reference to the Current Report on Form 8-K filed on December 20, 2021, as Exhibit 3.1 thereto.
     
3.3   By-Laws. Incorporated herein by reference to the Registration Statement on Form S-1 filed on November 5, 2021, as Exhibit 3.3 thereto.
     
31.1*   Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
31.2*   Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
     
32.1**   Certification of the Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
     
101.INS*   XBRL Instance Document.  The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document
     
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Filed herewith.
**Furnished herewith.

 

 24 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    Ault Disruptive Technologies Corporation  
Dated: May 23, 2023   /s/ William B. Horne  
    William B. Horne  
    Chief Executive Officer  
    (Principal Executive Officer)  
       
Dated: May 23, 2023   /s/ Kenneth S. Cragun  
    Kenneth S. Cragun  
    Chief Financial Officer  
    (Principal Financial and Accounting Officer)  

 

 

25

 

 

 

 

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

CERTIFICATION

 

I, William B. Horne, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of Ault Disruptive Technologies Corporation;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 23, 2023

 

/s/ William B. Horne  
Name: William B. Horne  
Title: Chief Executive Officer  
(Principal Executive Officer)  

 

 

 

 

 

 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

CERTIFICATION

 

I, Kenneth S. Cragun, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of Ault Disruptive Technologies Corporation;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated:  May 23, 2023

 

/s/ Kenneth S. Cragun  
Name: Kenneth S. Cragun  
Title: Chief Financial Officer  
(Principal Accounting Officer)  

 

 

 

 

 

 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Ault Disruptive Technologies Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: May 23, 2023  
   
   
  By: /s/ William B. Horne
  Name: William B. Horne
  Title: Chief Executive Officer
   (Principal Executive Officer)

 

Date: May 23, 2023  
   
   
  By: /s/ Kenneth S. Cragun
  Name: Kenneth S. Cragun
  Title: Chief Financial Officer
   (Principal Accounting Officer)

 

 

 

 

 

 

EX-101.SCH 5 adrt-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Business Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Private Placement Warrants link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Organization and Business Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Initial Public Offering (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Private Placement Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 adrt-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 adrt-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 adrt-20230331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units, each consisting of one share of Common Stock, par value $0.001 per share and three-fourths of one Redeemable Warrant to purchase one share of Common Stock Common Stock, $0.001 par value Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Sale of Stock [Axis] IPO [Member] Private Placement [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Over-Allotment Option [Member] Business Combination [Axis] Liquidation [Member] Common Stock Subject to Mandatory Redemption [Member] Non Redeemable Common Stock [Member] Related Party, Type [Axis] Sponsor [Member] Private Placement 1 [Member] Related Party Transaction [Axis] Administrative Services Agreement [Member] Founder Shares [Member] Statistical Measurement [Axis] Minimum [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity common stock, shares outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current asset - cash Prepaid expenses Cash and marketable securities held in Trust Account Total current assets Prepaid expenses, noncurrent Deferred tax asset, noncurrent Total Assets Liabilities and Stockholders’ Deficit Current liabilities: Accounts payable Accrued franchise taxes Income tax payable Common stock subject to possible redemption, 11,500,000 shares at redemption value(1) Total current liabilities Deferred underwriting commissions Total liabilities Stockholders’ Deficit: Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total Liabilities and Stockholders’ Deficit Common stock, shares authorized redemption Preferred stock, par value (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value (in dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Operating costs Loss from operations Other income: Income from investments held in trust account Interest expense, net Total other income Net income (loss) before income taxes Provision for income taxes Net income (loss) Basic and diluted weighted average shares outstanding, common stock subject to redemption Basic and diluted net income (loss) per share attributable to common stockholders Basic and diluted weighted average shares outstanding, common stock Beginning balance, value Balance at beginning (in shares) Remeasurement adjustment on redeemable common stock, net Net loss Ending balance, value Balance, end (in shares) Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Income from investments held in Trust Account Changes in current assets and current liabilities: Prepaid expenses Accounts payable Accrued expenses Tax payable Net cash used in operating activities Cash Flows from Investing Activities: Sale of investment held in Trust Account Net cash provided by investing activities Cash Flows from Financing Activities: Payments of offering costs Net cash used in financing activities Net change in cash Cash, beginning of the period Cash, end of the period Supplemental disclosure of noncash investing and financing activities: Remeasurement of common stock subject to possible redemption Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Business Operations Accounting Policies [Abstract] Basis of Presentation and Summary of Significant Accounting Policies Initial Public Offering Initial Public Offering Private Placement Warrants Private Placement Warrants Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Equity [Abstract] Stockholders’ Equity Fair Value Disclosures [Abstract] Fair Value Measurements Subsequent Events [Abstract] Subsequent Events Basis of Presentation Emerging Growth Company Status Use of Estimates Accounting Policy on Redeemable Shares Cash and Cash Equivalents Marketable Securities Held in Trust Account Concentration of Credit Risk Fair Value of Financial Instruments Offering Costs Associated with the Initial Public Offering Warrant Instruments Net Income (Loss) per Share of Common Stock Income Taxes Recent Accounting Pronouncements Schedule of common stock subject to possible redemption Schedule of reflects the calculation of basic and diluted Schedule of fair value on a recurring basis Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] BusinessCombinationAxis [Axis] Issuance of common stock to Sponsors (in shares) Sale of stock, price per share Aggregate units sold in the IPO Gross proceeds New issue of shares Description of stock issuance Option exercise generated gross proceeds Transaction cost Underwriting commissions Other offering costs Additional transaction cost Cash held from out side Cash Working capital amount Gross proceeds Proceeds allocated to Public Warrants Issuance costs allocated to common stock Remeasurement of carrying value to redemption value Common stock subject to possible redemption Remeasurement of common stock subject to possible redemption Common stock subject to possible redemption Allocation of net loss Basic and diluted weighted average shares outstanding  Basic and diluted net loss per common share Cash Asset, Held-in-Trust, Noncurrent Dividend Income, Operating Cash, FDIC insured amount Underwriting commissions Valuation allowance Stock issued during period, shares, new issues Shares purchase price (in dollars per share) Sale of stock, description of transaction Stock price per share Issuance of common stock to sponsors (in shares) Proceeds from Issuance of Common Stock Share price per unit Stock issued during period new issues Share price per unit Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Exercise price per share Exercise price per share Proceeds from issuance of Private Placement Warrants Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Shares issued for services Common stock, par or stated value per share Aggregate purchase price Common stock par or stated value per share Number of stock sold Underwriting fees Exercise price (in dollars per share) Business combination, reason for business combinations Sponsor fees Administrative service fees Business Combination, Control Obtained Description Underwriting commission of unit sold (per share) Underwriting commission of Unit sold in the IPO Value Deferred underwriting commisions Deferred underwriting commisions Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred stock, par value Common stock, shares, authorized Common stock, shares, outstanding Common stock, shares, issued Common stock value Class of warrant or right, expense or revenue recognized Warrant terms Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total assets The element represents aggregate units sold in ipo. The element represents gross proceeds. The element represents stock issued during period shares new issues. The element represents sale of stock description of transaction. The element represents underwriting commissions. The element represents deferred underwriting commissions. The element represents working capital amount. The element represents proceeds from issuance of common stock. The element represents proceeds allocated to private placement warrants. The element represents issuance costs allocated to common stock. The element represents accretion of carrying value to redemption value. The element represents common stock subject to possible redemption1. The element represents accretion of carrying value to redemption value one. Allocation of net income as adjusted. The element represents stock issued during period shares new issues one. The element represents shares purchase price per shares. The element represents sale of stock price per share1. The element represents stock issued during period shares new issues3. The element represents class of warrant or right exercise price of warrants or rights11. The element represents sale of stock price per share3. The element represents stock issued during period value issued for services one. The element represents common stock par or stated value per share1. The element represents underwriting fees. The element represents underwriting commission of unit sold in ipo value. The element represents underwriting commission of unit sold in ipo. The element represents common stock shares authorized redemption. The element represents common stock subject to possible redemption. The element represents underwriting commissions. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Income (Loss) Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding IncomeFromInvestments Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable, Trade Net Cash Provided by (Used in) Operating Activities InvestmentOfCashInTrustAccount Net Cash Provided by (Used in) Investing Activities PaymentOfOfferingCosts Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations InitialPublicOfferingDisclosureTextBlock PrivatePlacementTextBlock Proceeds From Issuance of Common Stock1 Common Stock Subject to Possible Redemption1 Accretion of Carrying Value to Redemption Value One Cash and Cash Equivalents, at Carrying Value UnderwritingCommission EX-101.PRE 9 adrt-20230331_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
3 Months Ended
Mar. 31, 2023
May 22, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41171  
Entity Registrant Name AULT DISRUPTIVE TECHNOLOGIES CORPORATION  
Entity Central Index Key 0001864032  
Entity Tax Identification Number 86-2279256  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 11411 Southern Highlands Pkwy  
Entity Address, Address Line Two Suite 240  
Entity Address, City or Town Las Vegas  
Entity Address, State or Province NV  
Entity Address, Postal Zip Code 89141  
City Area Code (949)  
Local Phone Number 444-5464  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company true  
Entity common stock, shares outstanding   14,375,000
Units, each consisting of one share of Common Stock, par value $0.001 per share and three-fourths of one Redeemable Warrant to purchase one share of Common Stock    
Title of 12(b) Security Units, each consisting of one share of Common Stock, par value  
Trading Symbol ADRU  
Security Exchange Name NYSEAMER  
Common Stock, $0.001 par value    
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol ADRT  
Security Exchange Name NYSEAMER  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Assets    
Current asset - cash $ 63,161 $ 206,527
Prepaid expenses 304,457 391,443
Cash and marketable securities held in Trust Account 119,254,187 118,193,123
Total current assets 119,621,805 118,791,093
Prepaid expenses, noncurrent 10,873
Deferred tax asset, noncurrent 27,062 27,062
Total Assets 119,648,867 118,829,028
Current liabilities:    
Accounts payable 136,276 60,952
Accrued franchise taxes 50,000 200,000
Income tax payable 623,846 285,003
Common stock subject to possible redemption, 11,500,000 shares at redemption value(1) 118,672,204 117,800,181
Total current liabilities 119,482,326 118,346,136
Deferred underwriting commissions 3,450,000 3,450,000
Total liabilities 122,932,326 121,796,136
Stockholders’ Deficit:    
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding 2,875 2,875
Additional paid-in capital
Accumulated deficit (3,286,334) (2,969,983)
Total stockholders’ deficit (3,283,459) (2,967,108)
Total Liabilities and Stockholders’ Deficit $ 119,648,867 $ 118,829,028
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, shares authorized redemption 11,500,000 11,500,000
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 2,875,000 2,875,000
Common stock, shares outstanding 2,875,000 2,875,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Operating costs $ 358,888 $ 296,891
Loss from operations (358,888) (296,891)
Other income:    
Income from investments held in trust account 1,253,403 11,754
Interest expense, net (3,063)
Total other income 1,253,403 8,691
Net income (loss) before income taxes 894,515 (288,200)
Provision for income taxes 338,843
Net income (loss) $ 555,672 $ (288,200)
Basic and diluted weighted average shares outstanding, common stock subject to redemption 11,500,000 11,500,000
Basic and diluted net income (loss) per share attributable to common stockholders $ 0.04 $ (0.02)
Basic and diluted weighted average shares outstanding, common stock 2,875,000 2,875,000
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 2,875 $ (1,766,410) $ (1,763,535)
Balance at beginning (in shares) at Dec. 31, 2021 2,875,000      
Net loss (288,200) (288,200)
Ending balance, value at Mar. 31, 2022 $ 2,875 (2,054,610) (2,051,735)
Balance, end (in shares) at Mar. 31, 2022 2,875,000      
Beginning balance, value at Dec. 31, 2022 $ 2,875 (2,969,983) (2,967,108)
Balance at beginning (in shares) at Dec. 31, 2022 2,875,000      
Remeasurement adjustment on redeemable common stock, net [1] (872,023) (872,023)
Net loss 555,672 555,672
Ending balance, value at Mar. 31, 2023 $ 2,875 $ (3,286,334) $ (3,283,459)
Balance, end (in shares) at Mar. 31, 2023 2,875,000      
[1] Remeasurement adjustment is net of amounts eligible to be withdrawn from the Trust Account to pay franchise and income taxes for the period.
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities:    
Net income (loss) $ 555,672 $ (288,200)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Income from investments held in Trust Account (1,253,403) (11,754)
Changes in current assets and current liabilities:    
Prepaid expenses 97,859 56,601
Accounts payable 75,324
Accrued expenses (346,067)
Tax payable 188,843
Net cash used in operating activities (335,705) (589,420)
Cash Flows from Investing Activities:    
Sale of investment held in Trust Account 192,339
Net cash provided by investing activities 192,339
Cash Flows from Financing Activities:    
Payments of offering costs (150,636)
Net cash used in financing activities (150,636)
Net change in cash (143,366) (740,056)
Cash, beginning of the period 206,527 1,849,679
Cash, end of the period 63,161 1,109,623
Supplemental disclosure of noncash investing and financing activities:    
Remeasurement of common stock subject to possible redemption $ 872,023
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Business Operations
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Business Operations

Note 1 — Organization and Business Operations

 

Organization

 

Ault Disruptive Technologies Corporation (the “Company” or “We”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.

 

As of March 31, 2023, the Company had not commenced any operations. All activity for the period from February 22, 2021 (“Inception”) through March 31, 2023, relates to the Company’s formation, the Initial Public Offering (“IPO” or “Public Offering”) described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate nonoperating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.

 

The Company’s Sponsor is Ault Disruptive Technologies Company, LLC, a Delaware limited liability company that is a wholly owned subsidiary of Ault Alliance, Inc., a Delaware corporation (NYSE American: AULT) (the “Sponsor”).

 

Financing 

 

The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of 10,000,000 units at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Simultaneously with the consummation of the IPO, the Company consummated the private placement of 6,500,000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

Transaction costs related to the IPO amounted to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions, and $784,000 of other offering costs. In addition, $1,849,679 of cash was held outside of the Trust Account (as defined below) and used for working capital purposes.

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

 

The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.

 

Trust Account

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company's initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company's initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company's public shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 18 months following the effectiveness of the Public Offering, the Company's return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company's public stockholders may receive only approximately $10.35 per public share on the liquidation of the Company's trust account and its warrants will expire worthlessly.

 

The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.

 

The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $10.35 per public share.

 

The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. 

 

The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 18 months following the effectiveness of the Public Offering (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.

 

The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 7), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).

 

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.35 per Public Share). 

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.35 per public share, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Going Concern

 

As of March 31, 2023, the Company had $63,161 in its operating bank account and working capital of $813,325, exclusive of taxes payable.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any.

 

The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. As of March 31, 2023, the Company has been unable to consummate its initial business combination, and it is uncertain that it will be able to consummate a business combination prior to our second extension deadline of June 20, 2023.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management continues to seek to complete a Business Combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 20, 2023. The accompanying unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

 

Risks and Uncertainties

 

The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. 

 

Management continues to evaluate the impact of the COVID-19 pandemic on the industry and currently believes that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

In February 2022, a military conflict started between Russia and Ukraine. The ongoing military conflict between Russia and Ukraine has provoked strong reactions from the United States, the United Kingdom, the European Union and various other countries around the world, including the imposition of broad financial and economic sanctions against Russia. Further, the precise effects of the ongoing military conflict and these sanctions on the global economies remain uncertain as of the date of the accompanying unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of the accompanying unaudited condensed financial statements.

 

Inflation Reduction Act

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

 

The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods.

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

Note 2 — Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected in the future.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 4, 2023.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  

 

Use of Estimates

 

The preparation of the financial statements is in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Accounting Policy on Redeemable Shares

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times shares of common stock will be classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of certain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.

 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero. 

 

As of March 31, 2023, Common Stock subject to possible redemption reflected in the unaudited condensed balance sheets are reconciled in the following table:

 

     
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to Common Stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   13,979,594 
Common Stock subject to possible redemption as of December 31, 2022   117,800,181 
Remeasurement of Common Stock subject to possible redemption   872,023 
Common Stock subject to possible redemption as of March 31, 2023  $118,672,204 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.

 

Marketable Securities Held in Trust Account

 

As of March 31, 2023 and December 31, 2022, the Company held $119,254,187 and $118,193,123, respectively, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2023, the Company withdrew $192,339 of dividend income from the Trust Account to pay its tax obligations.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

 

Offering Costs Associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to stockholders’ deficit. The Company incurred offering costs amounting to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions and $784,000 of other offering costs.

 

Warrant Instruments

 

The Company has accounted for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

 

Net Income (Loss) per Share of Common Stock

 

We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2023 and 2022 we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 

        
   For the Three Months Ended March 31, 2023 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net income per common share        
Numerator:        
Allocation of net income  $444,538   $111,134 
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net income per common share  $0.04   $0.04 

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

           
   For the Three Months Ended March 31, 2022 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net loss per common share        
Numerator:        
Allocation of net loss  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
 Basic and diluted net loss per common share  $(0.02)  $(0.02)

 

Income Taxes

 

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting, and ASC Topic 740, Income Taxes (“ASC 740”). The Company’s effective tax rate (“ETR”) from continuing operations was (38%) and (0%) for the three months ended March 31, 2023 and 2022, respectively. The Company recorded income tax expense of $338,843, and $0 for the three months ended March 31, 2023 and 2022, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to a U.S. federal valuation allowance.

 

A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. For the three months ended March 31, 2023 and 2022, the valuation allowance was $692,085 and $0, respectively.

 

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it had no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense. 

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Initial Public Offering
3 Months Ended
Mar. 31, 2023
Initial Public Offering  
Initial Public Offering

Note 3 — Initial Public Offering

 

On December 20, 2021, the Company consummated its IPO of 10,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were 11,500,000 and generated gross proceeds of $115,000,000

 

Following the closing of the IPO on December 20, 2021, $116,725,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $10.15 per Unit for the 11,500,000 Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $116,725,000 ($10.15 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. 

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Private Placement Warrants
3 Months Ended
Mar. 31, 2023
Private Placement Warrants  
Private Placement Warrants

Note 4 — Private Placement Warrants

 

Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 6,500,000 Private Placement Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021), each exercisable to purchase one share of Common Stock at $11.50 per share, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,100,000

 

The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).

 

If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 — Related Party Transactions

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2023 or 2022.

 

Private Placement Warrants

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants, except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering.

 

Administrative Services Agreement

 

The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $10,000 per month for these services. The Company incurred $30,000 in operating cost associated with the administrative service fees for each of the three months ended March 31, 2023 and 2022.

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 — Commitments and Contingencies

 

In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. 

 

Initial Business Combination Period Extension

 

On December 13, 2022, the Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “First Deposit”). The First Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the initial deadline of December 20, 2022, until March 20, 2023. When the Sponsor makes the First Deposit, it will receive 1,150,000 private placement warrants in connection with the First Deposit, however, this deposit has yet to be made.

 

On March 15, 2023, the Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “Second Deposit”). The Second Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the first extension deadline of March 20, 2023, until June 20, 2023. When the Sponsor makes the Second Deposit, it will receive 1,150,000 private placement warrants in connection with the Second Deposit, however, this deposit has yet to be made.

 

Registration and Shareholder Rights

 

The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common Stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. 

 

Underwriting Agreement

 

The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. 

 

The underwriters were paid at the closing of the IPO an underwriting commission of $0.25 per Unit sold in the IPO or $2,513,333. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $2,888,333 in underwriting commissions related to the IPO and over-allotment.

 

In addition, $3,000,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $3,450,000 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. 

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders’ Equity

Note 7 — Stockholders’ Equity

 

Preferred Stock

 

The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and 2022, there were no preferred shares issued or outstanding. 

 

Common Stock

 

The Company is authorized to issue 100,000,000 shares of Common Stock with a par value of $0.001 per share. As of March 31, 2023 and 2022, there were 2,875,000 shares of Common Stock outstanding, excluding 11,500,000 shares of Common Stock subject to possible redemption issued.

 

Founder Shares

 

On February 23, 2021, the Company issued the Sponsor an aggregate of 2,875,000 shares of the Company’s common stock, par value $0.001 per share (the “Founder Shares”) for an aggregate purchase price of $25,000. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2022 or 2023.

 

Public Warrants and Private Placement Warrants

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.

 

The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

 

If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

 

in whole and not in part;

 

at a price of $0.01 per warrant;

 

upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and

 

if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.

 

If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

 

The Sponsor purchased an aggregate of 7,100,000 Private Placement Warrants, which includes the 600,000 Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $1.00 per warrant, for an aggregate purchase price of $7,100,000. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 18 months following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 18-month period. However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 18-month period. 

 

All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 8 Fair Value Measurements

 

Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

                
   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2023   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $119,254,187   $119,254,187   $-   $- 
Total  $119,254,187   $119,254,187   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $118,193,123   $118,193,123   $-   $- 
Total  $118,193,123   $118,193,123   $-   $- 

 

There were no transfers between Levels 1, 2 or 3 for the period from Inception through March 31, 2023.

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected in the future.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 4, 2023.

 

Emerging Growth Company Status

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. 

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  

 

Use of Estimates

Use of Estimates

 

The preparation of the financial statements is in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Accounting Policy on Redeemable Shares

Accounting Policy on Redeemable Shares

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times shares of common stock will be classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of certain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.

 

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero. 

 

As of March 31, 2023, Common Stock subject to possible redemption reflected in the unaudited condensed balance sheets are reconciled in the following table:

 

     
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to Common Stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   13,979,594 
Common Stock subject to possible redemption as of December 31, 2022   117,800,181 
Remeasurement of Common Stock subject to possible redemption   872,023 
Common Stock subject to possible redemption as of March 31, 2023  $118,672,204 

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022.

 

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

 

As of March 31, 2023 and December 31, 2022, the Company held $119,254,187 and $118,193,123, respectively, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2023, the Company withdrew $192,339 of dividend income from the Trust Account to pay its tax obligations.

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. 

 

Offering Costs Associated with the Initial Public Offering

Offering Costs Associated with the Initial Public Offering

 

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to stockholders’ deficit. The Company incurred offering costs amounting to $6,297,333 consisting of $2,513,333 of underwriting commissions, $3,000,000 of deferred underwriting commissions, and $784,000 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $7,122,333 consisting of $2,888,333 of underwriting commissions, $3,450,000 of deferred underwriting commissions and $784,000 of other offering costs.

 

Warrant Instruments

Warrant Instruments

 

The Company has accounted for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. 

 

Net Income (Loss) per Share of Common Stock

Net Income (Loss) per Share of Common Stock

 

We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2023 and 2022 we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.

 

The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):

 

        
   For the Three Months Ended March 31, 2023 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net income per common share        
Numerator:        
Allocation of net income  $444,538   $111,134 
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net income per common share  $0.04   $0.04 

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

           
   For the Three Months Ended March 31, 2022 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net loss per common share        
Numerator:        
Allocation of net loss  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
 Basic and diluted net loss per common share  $(0.02)  $(0.02)

 

Income Taxes

Income Taxes

 

The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting, and ASC Topic 740, Income Taxes (“ASC 740”). The Company’s effective tax rate (“ETR”) from continuing operations was (38%) and (0%) for the three months ended March 31, 2023 and 2022, respectively. The Company recorded income tax expense of $338,843, and $0 for the three months ended March 31, 2023 and 2022, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to a U.S. federal valuation allowance.

 

A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. For the three months ended March 31, 2023 and 2022, the valuation allowance was $692,085 and $0, respectively.

 

The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it had no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense. 

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

 

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of common stock subject to possible redemption
     
Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (4,312,500)
Issuance costs allocated to Common Stock   (6,866,913)
Plus:     
Remeasurement of carrying value to redemption value   13,979,594 
Common Stock subject to possible redemption as of December 31, 2022   117,800,181 
Remeasurement of Common Stock subject to possible redemption   872,023 
Common Stock subject to possible redemption as of March 31, 2023  $118,672,204 
Schedule of reflects the calculation of basic and diluted
        
   For the Three Months Ended March 31, 2023 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net income per common share        
Numerator:        
Allocation of net income  $444,538   $111,134 
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
Basic and diluted net income per common share  $0.04   $0.04 

 

The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):

 

           
   For the Three Months Ended March 31, 2022 
   Common Stock
Subject to
Redemption
   Non
Redeemable
Common Stock
 
Basic and diluted net loss per common share        
Numerator:        
Allocation of net loss  $(230,560)  $(57,640)
Denominator:          
Basic and diluted weighted average shares outstanding   11,500,000    2,875,000 
           
 Basic and diluted net loss per common share  $(0.02)  $(0.02)
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of fair value on a recurring basis
                
   March 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2023   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $119,254,187   $119,254,187   $-   $- 
Total  $119,254,187   $119,254,187   $-   $- 

 

   December 31,  

Quoted

Prices In

Active

Markets

  

Significant

Other

Observable

Inputs

  

Significant

Other

Unobservable

Inputs

 
   2022   (Level 1)   (Level 2)   (Level 3) 
Description                
Assets:                
U.S. Money Market Funds held in Trust Account  $118,193,123   $118,193,123   $-   $- 
Total  $118,193,123   $118,193,123   $-   $- 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Business Operations (Details Narrative) - USD ($)
Dec. 20, 2021
Dec. 20, 2021
Dec. 20, 2021
Mar. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Deferred underwriting commissions       $ 3,450,000 $ 3,450,000
Cash held from out side       1,849,679  
Cash       63,161  
Working capital amount       $ 813,325  
Liquidation [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sale of stock, price per share       $ 10.35  
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Transaction cost       $ 6,297,333  
Underwriting commissions       2,513,333  
Deferred underwriting commissions $ 3,000,000 $ 3,000,000 $ 3,000,000 3,000,000  
Other offering costs       784,000  
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of common stock to Sponsors (in shares)   10,000,000 116,725,000    
Sale of stock, price per share $ 10.00 $ 10.00 $ 10.00    
Aggregate units sold in the IPO $ 11,500,000 $ 11,500,000 $ 11,500,000    
Gross proceeds $ 115,000,000 $ 115,000,000 115,000,000    
Option exercise generated gross proceeds     $ 116,725,000    
Private Placement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of common stock to Sponsors (in shares)     6,500,000    
Sale of stock, price per share $ 10.15 $ 10.15 $ 10.15    
New issue of shares     6,500,000    
Description of stock issuance     warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor    
Option exercise generated gross proceeds     $ 7,100,000    
Over-Allotment Option [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of common stock to Sponsors (in shares) 11,500,000   116,725,000    
Option exercise generated gross proceeds $ 115,000,000   $ 116,725,000    
Transaction cost       7,122,333  
Underwriting commissions       2,888,333  
Deferred underwriting commissions       3,450,000  
Other offering costs       784,000  
Additional transaction cost       $ 825,000  
Over-Allotment Option [Member] | IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Option exercise generated gross proceeds     2,888,333    
Transaction cost $ 3,450,000 $ 3,450,000 $ 3,450,000    
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
Accounting Policies [Abstract]  
Gross proceeds $ 115,000,000
Proceeds allocated to Public Warrants (4,312,500)
Issuance costs allocated to common stock (6,866,913)
Remeasurement of carrying value to redemption value 13,979,594
Common stock subject to possible redemption 117,800,181
Remeasurement of common stock subject to possible redemption 872,023
Common stock subject to possible redemption $ 118,672,204
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Details 1) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Common Stock Subject to Mandatory Redemption [Member]    
Allocation of net loss $ 444,538 $ (230,560)
Basic and diluted weighted average shares outstanding 11,500,000 11,500,000
 Basic and diluted net loss per common share $ 0.04 $ (0.02)
Non Redeemable Common Stock [Member]    
Allocation of net loss $ 111,134 $ (57,640)
Basic and diluted weighted average shares outstanding 2,875,000 2,875,000
 Basic and diluted net loss per common share $ 0.04 $ (0.02)
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 20, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Cash $ 0   $ 0  
Asset, Held-in-Trust, Noncurrent 119,254,187   118,193,123  
Dividend Income, Operating 192,339      
Cash, FDIC insured amount 250,000      
Deferred underwriting commissions 3,450,000   $ 3,450,000  
Provision for income taxes 338,843    
Valuation allowance 692,085 $ 0    
Over-Allotment Option [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Transaction cost 7,122,333      
Underwriting commissions 2,888,333      
Deferred underwriting commissions 3,450,000      
Other offering costs 784,000      
Underwriting commissions 2,888,333      
IPO [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Transaction cost 6,297,333      
Underwriting commissions 2,513,333      
Deferred underwriting commissions 3,000,000     $ 3,000,000
Other offering costs $ 784,000      
IPO [Member] | Over-Allotment Option [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Transaction cost       $ 3,450,000
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Initial Public Offering (Details Narrative)
Dec. 20, 2021
USD ($)
$ / shares
shares
Dec. 20, 2021
$ / shares
shares
Dec. 20, 2021
USD ($)
$ / shares
shares
IPO [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Shares purchase price (in dollars per share) $ 10.00    
Sale of stock, description of transaction Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant.    
Issuance of common stock to sponsors (in shares) | shares   10,000,000 116,725,000
Proceeds from Issuance of Common Stock | $     $ 116,725,000
Share price per unit $ 10.15 $ 10.15 $ 10.15
Share price per unit $ 10.00 10.00 $ 10.00
Over-Allotment Option [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Issuance of common stock to sponsors (in shares) | shares 11,500,000   116,725,000
Proceeds from Issuance of Common Stock | $ $ 115,000,000   $ 116,725,000
Private Placement [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sale of stock, description of transaction     Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021)
Stock price per share $ 1.00 1.00 $ 1.00
Issuance of common stock to sponsors (in shares) | shares     6,500,000
Proceeds from Issuance of Common Stock | $     $ 7,100,000
Stock issued during period new issues | shares     11,500,000
Share price per unit $ 10.15 10.15 $ 10.15
IPO [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Stock issued during period, shares, new issues | shares 10,000,000    
Stock price per share $ 11.50 $ 11.50 $ 11.50
IPO [Member] | Over-Allotment Option [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Proceeds from Issuance of Common Stock | $     $ 2,888,333
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Private Placement Warrants (Details Narrative) - Private Placement [Member]
Dec. 20, 2021
USD ($)
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]  
Issuance of common stock to sponsors (in shares) | shares 6,500,000
Sale of stock, description of transaction Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021)
Exercise price per share $ 11.50
Exercise price per share $ 1.00
Proceeds from issuance of Private Placement Warrants | $ $ 7,100,000
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Feb. 23, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]        
Common stock, par or stated value per share   $ 0.001   $ 0.001
Common stock par or stated value per share $ 12.00      
Business combination, reason for business combinations   There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering.    
Administrative Services Agreement [Member]        
Related Party Transaction [Line Items]        
Sponsor fees   $ 10,000    
Administrative service fees   30,000 $ 30,000  
Common Stock [Member]        
Related Party Transaction [Line Items]        
Common stock, par or stated value per share $ 0.001      
Sponsor [Member]        
Related Party Transaction [Line Items]        
Shares issued for services 2,875,000      
Aggregate purchase price $ 25,000      
Sponsor [Member] | Private Placement [Member]        
Related Party Transaction [Line Items]        
Aggregate purchase price   $ 7,100,000    
Number of stock sold   7,100,000    
Underwriting fees   $ 7,100,000    
Exercise price (in dollars per share)   $ 1.00    
Sponsor [Member] | Private Placement 1 [Member]        
Related Party Transaction [Line Items]        
Underwriting fees   $ 600,000    
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Dec. 20, 2021
Dec. 20, 2021
Mar. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Business Combination, Control Obtained Description     Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “First Deposit”). The First Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the initial deadline of December 20, 2022, until March 20, 2023. When the Sponsor makes the First Deposit, it will receive 1,150,000 private placement warrants in connection with the First Deposit, however, this deposit has yet to be made.  
Deferred underwriting commisions     $ 3,450,000 $ 3,450,000
Over-Allotment Option [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Proceeds from Issuance of Common Stock $ 115,000,000 $ 116,725,000    
Deferred underwriting commisions     3,450,000  
Deferred underwriting commisions     7,122,333  
IPO [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Underwriting commission of unit sold (per share)   $ 0.25    
Underwriting commission of Unit sold in the IPO Value   $ 2,513,333    
Deferred underwriting commisions 3,000,000 3,000,000 3,000,000  
Deferred underwriting commisions     $ 6,297,333  
IPO [Member] | Over-Allotment Option [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Proceeds from Issuance of Common Stock   2,888,333    
Deferred underwriting commisions $ 3,450,000 $ 3,450,000    
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Feb. 23, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Preferred stock, shares authorized 1,000,000 1,000,000  
Preferred stock, par value $ 0.001 $ 0.001  
Preferred stock, shares issued 0 0  
Preferred stock, shares outstanding 0 0  
Common stock, shares, authorized 100,000,000 100,000,000  
Common stock, par or stated value per share $ 0.001 $ 0.001  
Common stock, shares, outstanding 2,875,000 2,875,000  
Common stock, shares authorized redemption 11,500,000 11,500,000  
Common stock, shares, issued 2,875,000 2,875,000  
Common stock value $ 2,875 $ 2,875 $ 25,000
Class of warrant or right, expense or revenue recognized The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.    
Private Placement [Member] | Minimum [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant terms 18 months    
Sponsor [Member] | Private Placement [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Underwriting fees $ 7,100,000    
Exercise price (in dollars per share) $ 1.00    
Sponsor [Member] | Private Placement 1 [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Underwriting fees $ 600,000    
Founder Shares [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, shares, issued     2,875,000
Common Stock [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, par or stated value per share     $ 0.001
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 119,254,187 $ 118,193,123
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 119,254,187 118,193,123
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Money Market Funds [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 119,254,187 118,193,123
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 119,254,187 118,193,123
Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets
XML 38 g5523010q_htm.xml IDEA: XBRL DOCUMENT 0001864032 2023-01-01 2023-03-31 0001864032 adrt:UnitsEachConsistingOfOneShareOfcommonStockParValue0.001PerShareandThreefourthsOfOneRedeemableWarrantToPurchaseOneShareOfCommonStockMember 2023-01-01 2023-03-31 0001864032 adrt:CommonStock0.001ParValueMember 2023-01-01 2023-03-31 0001864032 2023-05-22 0001864032 2023-03-31 0001864032 2022-12-31 0001864032 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2022-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001864032 us-gaap:RetainedEarningsMember 2022-12-31 0001864032 us-gaap:CommonStockMember 2021-12-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001864032 us-gaap:RetainedEarningsMember 2021-12-31 0001864032 2021-12-31 0001864032 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001864032 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001864032 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001864032 us-gaap:CommonStockMember 2023-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001864032 us-gaap:RetainedEarningsMember 2023-03-31 0001864032 us-gaap:CommonStockMember 2022-03-31 0001864032 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001864032 us-gaap:RetainedEarningsMember 2022-03-31 0001864032 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-13 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-18 2021-12-20 0001864032 us-gaap:IPOMember 2023-03-31 0001864032 us-gaap:OverAllotmentOptionMember 2023-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:PrivatePlacementMember 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-19 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember 2021-12-18 2021-12-20 0001864032 adrt:LiquidationMember 2023-03-31 0001864032 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-01-01 2023-03-31 0001864032 adrt:NonRedeemableCommonStockMember 2023-01-01 2023-03-31 0001864032 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2022-01-01 2022-03-31 0001864032 adrt:NonRedeemableCommonStockMember 2022-01-01 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-19 2021-12-20 0001864032 us-gaap:IPOMember 2021-12-20 0001864032 adrt:SponsorMember 2021-02-22 2021-02-23 0001864032 us-gaap:CommonStockMember 2021-02-23 0001864032 2021-02-23 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001864032 adrt:SponsorMember adrt:PrivatePlacement1Member 2023-01-01 2023-03-31 0001864032 adrt:SponsorMember us-gaap:PrivatePlacementMember 2023-03-31 0001864032 adrt:AdministrativeServicesAgreementMember 2023-01-01 2023-03-31 0001864032 adrt:AdministrativeServicesAgreementMember 2022-01-01 2022-03-31 0001864032 us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember us-gaap:IPOMember 2021-12-18 2021-12-20 0001864032 us-gaap:OverAllotmentOptionMember us-gaap:IPOMember 2021-12-20 0001864032 adrt:FounderSharesMember 2021-02-23 0001864032 srt:MinimumMember us-gaap:PrivatePlacementMember 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001864032 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001864032 us-gaap:MoneyMarketFundsMember 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001864032 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001864032 us-gaap:FairValueInputsLevel3Member 2022-12-31 iso4217:USD shares iso4217:USD shares 0001864032 false --12-31 2023 Q1 10-Q true 2023-03-31 false 001-41171 AULT DISRUPTIVE TECHNOLOGIES CORPORATION DE 86-2279256 11411 Southern Highlands Pkwy Suite 240 Las Vegas NV 89141 (949) 444-5464 Units, each consisting of one share of Common Stock, par value ADRU NYSEAMER Common Stock, $0.001 par value ADRT NYSEAMER Yes Yes Non-accelerated Filer true true false true 14375000 63161 206527 304457 391443 119254187 118193123 119621805 118791093 10873 27062 27062 119648867 118829028 136276 60952 50000 200000 623846 285003 11500000 11500000 118672204 117800181 119482326 118346136 3450000 3450000 122932326 121796136 0.001 0.001 1000000 1000000 0 0 0 0 0.001 0.001 100000000 100000000 2875000 2875000 2875000 2875000 2875 2875 -3286334 -2969983 -3283459 -2967108 119648867 118829028 358888 296891 -358888 -296891 1253403 11754 -3063 1253403 8691 894515 -288200 338843 555672 -288200 11500000 11500000 0.04 -0.02 2875000 2875000 0.04 -0.02 2875000 2875 -2969983 -2967108 -872023 -872023 555672 555672 2875000 2875 -3286334 -3283459 2875000 2875 -1766410 -1763535 -288200 -288200 2875000 2875 -2054610 -2051735 555672 -288200 1253403 11754 -97859 -56601 75324 -346067 188843 -335705 -589420 -192339 192339 150636 -150636 -143366 -740056 206527 1849679 63161 1109623 872023 <p id="xdx_808_eus-gaap--NatureOfOperations_zpopFUPcchrg" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 1 — <span id="xdx_82E_z4UbVQBKdBek">Organization and Business Operations</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Organization </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ault Disruptive Technologies Corporation (the “Company” or “We”) is a blank check company organized on February 22, 2021, under the laws of the State of Delaware. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities (“Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on companies with innovative and emerging technologies, products or services in the United States.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2023, the Company had not commenced any operations. All activity for the period from February 22, 2021 (“Inception”) through March 31, 2023, relates to the Company’s formation, the Initial Public Offering (“IPO” or “Public Offering”) described below and the search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate nonoperating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company’s Sponsor is Ault Disruptive Technologies Company, LLC, a Delaware limited liability company that is a wholly owned subsidiary of Ault Alliance, Inc., a Delaware corporation (NYSE American: AULT) (the “Sponsor”).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Financing</b> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The registration statement for the Company’s IPO was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its IPO of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211213__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zjf2ToXd673l" title="Issuance of common stock to Sponsors (in shares)">10,000,000</span> units at $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zsNmv3cqzOE3" title="Sale of stock, price per share">10.00</span> per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one share of common stock, par value of $0.001 per share (the “Common Stock”), and three-fourths of one redeemable warrant (the “Public Warrants”). Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $11.50 per share. On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were <span id="xdx_90A_ecustom--AggregateUnitsSoldInIpo_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Aggregate units sold in the IPO">11,500,000</span> and generated gross proceeds of $<span id="xdx_903_ecustom--GrossProceeds_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Gross proceeds">115,000,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.75in; background-color: white">Simultaneously with the consummation of the IPO, the Company consummated the private placement of <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesNewIssues2_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="New issue of shares">6,500,000</span> <span id="xdx_900_ecustom--SaleOfStockDescriptionOfTransaction1_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember" title="Description of stock issuance">warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor</span>, at a price of $1.00 per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Option exercise generated gross proceeds">7,100,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Transaction costs related to the IPO amounted to $<span id="xdx_903_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Transaction cost">6,297,333</span> consisting of $<span id="xdx_906_ecustom--UnderwritingCommissions_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Underwriting commissions">2,513,333</span> of underwriting commissions, $<span id="xdx_904_ecustom--DeferredUnderwritingCommissions_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Deferred underwriting commissions">3,000,000</span> of deferred underwriting commissions, and $<span id="xdx_90B_eus-gaap--OtherOwnershipInterestsOfferingCosts_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Other offering costs">784,000</span> of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $<span id="xdx_905_ecustom--AdditionalTransactionCost_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziEmBE2ufz33" title="Additional transaction cost">825,000</span> in transaction costs for aggregate transaction costs of $<span id="xdx_903_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Transaction cost">7,122,333</span> consisting of $<span id="xdx_900_ecustom--UnderwritingCommissions_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Underwriting commissions">2,888,333</span> of underwriting commissions, $<span id="xdx_904_ecustom--DeferredUnderwritingCommissions_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Deferred underwriting commissions">3,450,000</span> of deferred underwriting commissions, and $<span id="xdx_909_eus-gaap--OtherOwnershipInterestsOfferingCosts_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Other offering costs">784,000</span> of other offering costs. In addition, $<span id="xdx_904_eus-gaap--AssetsHeldInTrust_iI_c20230331_zSeDKlZfYp39" title="Cash held from out side">1,849,679</span> of cash was held outside of the Trust Account (as defined below) and used for working capital purposes.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Initial Business Combination</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Trust Account</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following the closing of the IPO on December 20, 2021, $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Issuance of common stock to Sponsors (in shares)">116,725,000</span> from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of stock, price per share">10.15</span> per Unit for the <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Issuance of common stock to Sponsors (in shares)">11,500,000</span> Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Issuance of common stock to Sponsors (in shares)">116,725,000</span> was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), the Company intends to avoid being deemed an “investment company” within the meaning of the Investment Company Act. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the consummation of the Company's initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend its amended and restated certificate of incorporation (A) to modify the substance or timing of its obligation to allow redemptions in connection with the Company's initial Business Combination or certain amendments to its charter prior thereto or to redeem 100% of the Company's public shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or (B) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 18 months following the effectiveness of the Public Offering, the Company's return of the funds held in the trust account to its public stockholders as part of its redemption of the public shares. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment Company Act. If the Company is deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which the Company has not allotted funds and may hinder its ability to consummate an initial Business Combination or may result in its liquidation. If the Company is unable to consummate its initial Business Combination, the Company's public stockholders may receive only approximately $10.35 per public share on the liquidation of the Company's trust account and its warrants will expire worthlessly.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will provide holders (the “Public Shareholders”) of its Common Stock sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely at its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Common Stock upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is currently anticipated to be $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_c20230331__custom--BusinessCombinationAxis__custom--LiquidationMember_pdd" title="Sale of stock, price per share">10.35</span> per public share.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The per share amount the Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the Public Shares, even if a Public Shareholder has properly elected to redeem its shares if a Business Combination does not close. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Common Stock subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated articles of incorporation provides that the Company will have only 18 months following the effectiveness of the Public Offering (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, if any (less up to $50,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and its board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate an initial Business Combination within the Combination Period.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Sponsor and each member of its management team have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (defined in Note 7), Private Placement Warrants and Public Shares held by them (ii) to waive their redemption rights with respect to their Founder Shares, Private Placement Warrants and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) that would modify the substance or timing of the Company’s obligation to provide holders of shares of Common Stock the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of shares of Common Stock or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Private Placement Warrants they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Private Placement Warrants if the Company fails to consummate a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to consummate a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not consummate a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.35 per Public Share). </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.35 per public share, and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses, or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Liquidity and Going Concern</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2023, the Company had $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230331_zkgmv7saN6Gi" title="Cash">63,161 </span>in its operating bank account and working capital of $<span id="xdx_906_ecustom--WorkingCapitalAmount_iI_pp0p0_c20230331_zRrpavdFW8F" title="Working capital amount">813,325</span>, exclusive of taxes payable.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. As of March 31, 2023, the Company has been unable to consummate its initial business combination, and it is uncertain that it will be able to consummate a business combination prior to our second extension deadline of June 20, 2023.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), management has determined that the liquidity condition, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management continues to seek to complete a Business Combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 20, 2023. The accompanying unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Risks and Uncertainties</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company has a limited operating history and has not yet generated revenue from intended operations. The Company’s business and operations are sensitive to general business and economic conditions in the U.S. along with local, state, and federal government policy decisions. A host of factors beyond the Company’s control could cause fluctuations in these conditions, including but not limited to, credit risk, and changes to regulations governing the Company’s industry. Adverse developments in this general business and economic conditions could have a material adverse effect on the Company’s financial condition and the results of its operations. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management continues to evaluate the impact of the COVID-19 pandemic on the industry and currently believes that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or searching for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In February 2022, a military conflict started between Russia and Ukraine. The ongoing military conflict between Russia and Ukraine has provoked strong reactions from the United States, the United Kingdom, the European Union and various other countries around the world, including the imposition of broad financial and economic sanctions against Russia. Further, the precise effects of the ongoing military conflict and these sanctions on the global economies remain uncertain as of the date of the accompanying unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of the accompanying unaudited condensed financial statements.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b>Inflation Reduction Act</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 10000000 10.00 11500000 115000000 6500000 warrants (7,100,000 warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) (the “Private Placement Warrants”) to the Sponsor 7100000 6297333 2513333 3000000 784000 825000 7122333 2888333 3450000 784000 1849679 116725000 10.15 11500000 116725000 10.35 63161 813325 <p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zAlaHjY8yeRd" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 2 — <span id="xdx_820_zrLxPVofPRce">Basis of Presentation and Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5dlctz7CPf3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zBimu4PKBuph">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected in the future.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 4, 2023.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_841_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zSJQL7Z0rMr3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zUwE5mexbls5">Emerging Growth Company Status</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--UseOfEstimates_zWsAFAO2jgz2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_z0R2Sp0XAAX">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the financial statements is in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84B_ecustom--AccountingPolicyOnRedeemableSharesPolicyTextBlock_zsQudsbuSUZi" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_869_ztP4Fi9LsXEk">Accounting Policy on Redeemable Shares</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times shares of common stock will be classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of certain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">As of March 31, 2023, Common Stock subject to possible redemption reflected in the unaudited condensed balance sheets are reconciled in the following table:</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--RedeemableSharesTableTextBlock_zXUV3meXxSRl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zd638weR6086" style="display: none">Schedule of common stock subject to possible redemption</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ProceedsFromIssuanceOfCommonStock1_c20230101__20230331_pp0p0" style="width: 15%; text-align: right" title="Gross proceeds">115,000,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_c20230101__20230331_pp0p0" style="text-align: right" title="Proceeds allocated to Public Warrants">(4,312,500</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left">Issuance costs allocated to Common Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--IssuanceCostsAllocatedToCommonStock_c20230101__20230331_pp0p0" style="text-align: right" title="Issuance costs allocated to common stock">(6,866,913</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20230331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">13,979,594</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Common Stock subject to possible redemption as of December 31, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption1_iS_pp0p0_c20230101__20230331_zId6MG9uFfn8" style="padding-bottom: 1pt; text-align: right" title="Common stock subject to possible redemption">117,800,181</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Remeasurement of Common Stock subject to possible redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AccretionOfCarryingValueToRedemptionValueOne_pp0p0_c20230101__20230331_zn3JYoSpEYSc" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of common stock subject to possible redemption">872,023</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Common Stock subject to possible redemption as of March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption1_iE_pp0p0_c20230101__20230331_zS6KuRjEPF79" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption">118,672,204</td><td style="padding-bottom: 2.5pt; white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zhwhLpxBVvfb" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF68hxk2XUm3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_865_zlJ51LXYmG22">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_do_c20230331_zrPxxUtLj7Bc" title="Cash"><span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_do_c20221231_zLydHVF3Puw3" title="Cash">no</span></span> cash equivalents as of March 31, 2023 and December 31, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_zCDCG3JTFX77" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_866_zlGlJF7d27pd">Marketable Securities Held in Trust Account</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As of March 31, 2023 and December 31, 2022, the Company held $<span id="xdx_90B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20230331_zB5YPOTtgf29">119,254,187</span> and $<span id="xdx_90D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20221231_z4kQbs5E3mXg">118,193,123</span>, respectively, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2023, the Company withdrew $<span id="xdx_90C_eus-gaap--DividendIncomeOperating_c20230101__20230331_zRelOiJqdiXj">192,339 </span>of dividend income from the Trust Account to pay its tax obligations.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z6APTG7Um4ek" style="font: 10pt Times New Roman; margin: 0pt 0"><b><span id="xdx_864_zB3PGkhpwHAi">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zFJHyWI9psJ1" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zTDTDLBmwevd" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86A_z3UAq31u4bB2">Fair Value of Financial Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84C_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_zpXtg1w7QFJk" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_868_zIgGM4t152ae">Offering Costs Associated with the Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to stockholders’ deficit. The Company incurred offering costs amounting to $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zDODBAsdL8Mj" title="Transaction cost">6,297,333</span> consisting of $<span id="xdx_906_ecustom--UnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zJSbyGmJ4cfi" title="Underwriting commissions">2,513,333</span> of underwriting commissions, $<span id="xdx_90C_ecustom--DeferredUnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zuWlTEVASlAd" title="Deferred underwriting commissions">3,000,000</span> of deferred underwriting commissions, and $<span id="xdx_909_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zdrfsY5T5hbh" title="Other offering costs">784,000</span> of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zG4fUFsF9qed" title="Transaction cost">7,122,333</span> consisting of $<span id="xdx_906_ecustom--UnderwritingCommission_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpFx4YzUkG71" title="Underwriting commissions">2,888,333</span> of underwriting commissions, $<span id="xdx_90B_ecustom--DeferredUnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrj2Iux08dxg" title="Deferred underwriting commissions">3,450,000</span> of deferred underwriting commissions and $<span id="xdx_907_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0UBWydDOOn3" title="Other offering costs">784,000</span> of other offering costs.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84F_ecustom--WarrantInstrumentsPolicyTextBlock_zKqg5PsdImbl" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_861_z4t39Uw4Dro8">Warrant Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company has accounted for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zVGe0CDKNxyc" style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b><span id="xdx_86D_zdps57eFIRGc">Net Income (Loss) per Share of Common Stock</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2023 and 2022 we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_znx7BOpEfDYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BD_zuBfbVTnzQef" style="display: none">Schedule of reflects the calculation of basic and diluted</span></td><td> </td> <td colspan="2" id="xdx_495_20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_z3Xz2APMWUI8" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" id="xdx_497_20230101__20230331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zGSf7tibFNod" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2023</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net income per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_ecustom--AllocationOfNetIncomeAsAdjusted_zB4qoXNilHKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">444,538</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">111,134</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_zLqRR3xAhoU5" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zO4Zy3qyUTP7" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_406_ecustom--AllocationOfNetIncomeAsAdjusted_zTlbhgDvMSS8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(230,560</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(57,640</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zXxMLyIGqbR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_znWiW9mBH4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Basic and diluted net loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zWmrE2PaeeXk" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zpr6QahJLkh2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_867_znMw1zQ3G9q4">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting, and ASC Topic 740, Income Taxes (“ASC 740”). The Company’s effective tax rate (“ETR”) from continuing operations was (38%) and (0%) for the three months ended March 31, 2023 and 2022, respectively. The Company recorded income tax expense of $<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230101__20230331_zE4XSXz7SlUh" title="Provision for income taxes">338,843</span>, and $0 for the three months ended March 31, 2023 and 2022, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to a U.S. federal valuation allowance.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. For the three months ended March 31, 2023 and 2022, the valuation allowance was $<span id="xdx_90E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230101__20230331_zkBpJrLIQGSg" title="Valuation allowance">692,085</span> and $<span id="xdx_902_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20220331_zmD1o8JfQH41" title="Valuation allowance">0</span>, respectively.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it had no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbGtX6OrWKel" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zk4n4MD1Dv7i">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z5dlctz7CPf3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_zBimu4PKBuph">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected in the future.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K filed by the Company with the SEC on April 4, 2023.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_841_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zSJQL7Z0rMr3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zUwE5mexbls5">Emerging Growth Company Status</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.  </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_844_eus-gaap--UseOfEstimates_zWsAFAO2jgz2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_862_z0R2Sp0XAAX">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The preparation of the financial statements is in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84B_ecustom--AccountingPolicyOnRedeemableSharesPolicyTextBlock_zsQudsbuSUZi" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_869_ztP4Fi9LsXEk">Accounting Policy on Redeemable Shares</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) will be classified as a liability instrument and measured at fair value. Conditionally redeemable shares of common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times shares of common stock will be classified as stockholders’ equity. The Company’s common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of certain future events. Accordingly, 11,500,000 shares of common stock subject to possible redemption are presented at redemption value as a current liability in the Company’s balance sheet, as the deposits required to extend the time we have to consummate our initial business combination have not yet been made.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the shares of Common Stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of Common Stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital is zero. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">As of March 31, 2023, Common Stock subject to possible redemption reflected in the unaudited condensed balance sheets are reconciled in the following table:</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--RedeemableSharesTableTextBlock_zXUV3meXxSRl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zd638weR6086" style="display: none">Schedule of common stock subject to possible redemption</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ProceedsFromIssuanceOfCommonStock1_c20230101__20230331_pp0p0" style="width: 15%; text-align: right" title="Gross proceeds">115,000,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_c20230101__20230331_pp0p0" style="text-align: right" title="Proceeds allocated to Public Warrants">(4,312,500</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left">Issuance costs allocated to Common Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--IssuanceCostsAllocatedToCommonStock_c20230101__20230331_pp0p0" style="text-align: right" title="Issuance costs allocated to common stock">(6,866,913</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20230331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">13,979,594</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Common Stock subject to possible redemption as of December 31, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption1_iS_pp0p0_c20230101__20230331_zId6MG9uFfn8" style="padding-bottom: 1pt; text-align: right" title="Common stock subject to possible redemption">117,800,181</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Remeasurement of Common Stock subject to possible redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AccretionOfCarryingValueToRedemptionValueOne_pp0p0_c20230101__20230331_zn3JYoSpEYSc" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of common stock subject to possible redemption">872,023</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Common Stock subject to possible redemption as of March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption1_iE_pp0p0_c20230101__20230331_zS6KuRjEPF79" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption">118,672,204</td><td style="padding-bottom: 2.5pt; white-space: nowrap; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zhwhLpxBVvfb" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--RedeemableSharesTableTextBlock_zXUV3meXxSRl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zd638weR6086" style="display: none">Schedule of common stock subject to possible redemption</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left">Gross proceeds</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ProceedsFromIssuanceOfCommonStock1_c20230101__20230331_pp0p0" style="width: 15%; text-align: right" title="Gross proceeds">115,000,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-align: left">Proceeds allocated to Public Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ProceedsAllocatedToPrivatePlacementWarrants_c20230101__20230331_pp0p0" style="text-align: right" title="Proceeds allocated to Public Warrants">(4,312,500</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; text-align: left">Issuance costs allocated to Common Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--IssuanceCostsAllocatedToCommonStock_c20230101__20230331_pp0p0" style="text-align: right" title="Issuance costs allocated to common stock">(6,866,913</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 9pt; padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--AccretionOfCarryingValueToRedemptionValue_c20230101__20230331_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">13,979,594</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Common Stock subject to possible redemption as of December 31, 2022</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_989_ecustom--CommonStockSubjectToPossibleRedemption1_iS_pp0p0_c20230101__20230331_zId6MG9uFfn8" style="padding-bottom: 1pt; text-align: right" title="Common stock subject to possible redemption">117,800,181</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Remeasurement of Common Stock subject to possible redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--AccretionOfCarryingValueToRedemptionValueOne_pp0p0_c20230101__20230331_zn3JYoSpEYSc" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of common stock subject to possible redemption">872,023</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Common Stock subject to possible redemption as of March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--CommonStockSubjectToPossibleRedemption1_iE_pp0p0_c20230101__20230331_zS6KuRjEPF79" style="border-bottom: Black 2.5pt double; text-align: right" title="Common stock subject to possible redemption">118,672,204</td><td style="padding-bottom: 2.5pt; white-space: nowrap; text-align: left"> </td></tr> </table> 115000000 -4312500 -6866913 13979594 117800181 872023 118672204 <p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF68hxk2XUm3" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_865_zlJ51LXYmG22">Cash and Cash Equivalents</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_do_c20230331_zrPxxUtLj7Bc" title="Cash"><span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_do_c20221231_zLydHVF3Puw3" title="Cash">no</span></span> cash equivalents as of March 31, 2023 and December 31, 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 0 0 <p id="xdx_846_eus-gaap--MarketableSecuritiesPolicy_zCDCG3JTFX77" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_866_zlGlJF7d27pd">Marketable Securities Held in Trust Account</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As of March 31, 2023 and December 31, 2022, the Company held $<span id="xdx_90B_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20230331_zB5YPOTtgf29">119,254,187</span> and $<span id="xdx_90D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20221231_z4kQbs5E3mXg">118,193,123</span>, respectively, which was invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. During the three months ended March 31, 2023, the Company withdrew $<span id="xdx_90C_eus-gaap--DividendIncomeOperating_c20230101__20230331_zRelOiJqdiXj">192,339 </span>of dividend income from the Trust Account to pay its tax obligations.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 119254187 118193123 192339 <p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z6APTG7Um4ek" style="font: 10pt Times New Roman; margin: 0pt 0"><b><span id="xdx_864_zB3PGkhpwHAi">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20230331_zFJHyWI9psJ1" title="Cash, FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 250000 <p id="xdx_84B_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zTDTDLBmwevd" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86A_z3UAq31u4bB2">Fair Value of Financial Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84C_ecustom--OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock_zpXtg1w7QFJk" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_868_zIgGM4t152ae">Offering Costs Associated with the Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs are allocated ratably with the redeemable and non-redeemable shares they are allocated to. Offering costs associated with warrants and shares of Common Stock not subject to redemption are charged to stockholders’ deficit. The Company incurred offering costs amounting to $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zDODBAsdL8Mj" title="Transaction cost">6,297,333</span> consisting of $<span id="xdx_906_ecustom--UnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zJSbyGmJ4cfi" title="Underwriting commissions">2,513,333</span> of underwriting commissions, $<span id="xdx_90C_ecustom--DeferredUnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zuWlTEVASlAd" title="Deferred underwriting commissions">3,000,000</span> of deferred underwriting commissions, and $<span id="xdx_909_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_pp0p0_c20230331__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zdrfsY5T5hbh" title="Other offering costs">784,000</span> of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $825,000 in transaction costs for aggregate transaction costs of $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zG4fUFsF9qed" title="Transaction cost">7,122,333</span> consisting of $<span id="xdx_906_ecustom--UnderwritingCommission_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpFx4YzUkG71" title="Underwriting commissions">2,888,333</span> of underwriting commissions, $<span id="xdx_90B_ecustom--DeferredUnderwritingCommissions_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrj2Iux08dxg" title="Deferred underwriting commissions">3,450,000</span> of deferred underwriting commissions and $<span id="xdx_907_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_pp0p0_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z0UBWydDOOn3" title="Other offering costs">784,000</span> of other offering costs.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 6297333 2513333 3000000 784000 7122333 2888333 3450000 784000 <p id="xdx_84F_ecustom--WarrantInstrumentsPolicyTextBlock_zKqg5PsdImbl" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_861_z4t39Uw4Dro8">Warrant Instruments</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company has accounted for the 8,625,000 Public Warrants and the 7,100,000 Private Placement Warrants issued in connection with the IPO and Private Placement in accordance with the guidance contained in ASC 480, “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, or whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the holders could potentially require "net cash settlement" in a circumstance outside of the Company’s control, among other conditions for equity classification. The Public and Private Placement Warrants were deemed to meet equity classification. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zVGe0CDKNxyc" style="font: 10pt Times New Roman; margin: 0pt 0; background-color: white"><b><span id="xdx_86D_zdps57eFIRGc">Net Income (Loss) per Share of Common Stock</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We comply with accounting and disclosure requirements of the Financial Accounting Standards Board (‘FASB”) ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Remeasurement associated with the redeemable shares of common stock is excluded from net loss per share as the redemption value approximates fair value. At March 31, 2023 and 2022 we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in our earnings. As a result, diluted loss per share is the same as basic loss per share for the period presented.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_znx7BOpEfDYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BD_zuBfbVTnzQef" style="display: none">Schedule of reflects the calculation of basic and diluted</span></td><td> </td> <td colspan="2" id="xdx_495_20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_z3Xz2APMWUI8" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" id="xdx_497_20230101__20230331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zGSf7tibFNod" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2023</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net income per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_ecustom--AllocationOfNetIncomeAsAdjusted_zB4qoXNilHKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">444,538</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">111,134</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_zLqRR3xAhoU5" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zO4Zy3qyUTP7" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_406_ecustom--AllocationOfNetIncomeAsAdjusted_zTlbhgDvMSS8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(230,560</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(57,640</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zXxMLyIGqbR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_znWiW9mBH4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Basic and diluted net loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zWmrE2PaeeXk" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_znx7BOpEfDYc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BD_zuBfbVTnzQef" style="display: none">Schedule of reflects the calculation of basic and diluted</span></td><td> </td> <td colspan="2" id="xdx_495_20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_z3Xz2APMWUI8" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" id="xdx_497_20230101__20230331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zGSf7tibFNod" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2023</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net income per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_ecustom--AllocationOfNetIncomeAsAdjusted_zB4qoXNilHKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">444,538</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">111,134</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Basic and diluted net income per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.04</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockSubjectToMandatoryRedemptionMember_zLqRR3xAhoU5" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20220101__20220331__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableCommonStockMember_zO4Zy3qyUTP7" style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended March 31, 2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Common Stock<br/> Subject to <br/> Redemption</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Non<br/> Redeemable<br/> Common Stock</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-style: italic">Basic and diluted net loss per common share</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Numerator:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr id="xdx_406_ecustom--AllocationOfNetIncomeAsAdjusted_zTlbhgDvMSS8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; padding-left: 0.5in">Allocation of net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(230,560</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">(57,640</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedWeightedAverageSharesOutstanding_zXxMLyIGqbR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5in">Basic and diluted weighted average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerCommonShare_znWiW9mBH4B8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Basic and diluted net loss per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="white-space: nowrap; text-align: left">)</td></tr> </table> 444538 111134 11500000 2875000 0.04 0.04 -230560 -57640 11500000 2875000 -0.02 -0.02 <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zpr6QahJLkh2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_867_znMw1zQ3G9q4">Income Taxes</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company calculates its interim income tax provision in accordance with ASC Topic 270, Interim Reporting, and ASC Topic 740, Income Taxes (“ASC 740”). The Company’s effective tax rate (“ETR”) from continuing operations was (38%) and (0%) for the three months ended March 31, 2023 and 2022, respectively. The Company recorded income tax expense of $<span id="xdx_90A_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20230101__20230331_zE4XSXz7SlUh" title="Provision for income taxes">338,843</span>, and $0 for the three months ended March 31, 2023 and 2022, respectively. The difference between the ETR and federal statutory rate of 21.0% is primarily attributable to a U.S. federal valuation allowance.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A valuation allowance is recorded when it is more-likely-than-not some of the Company’s deferred tax assets may not be realized. Significant judgment is applied when assessing the need for a valuation allowance and the Company considers future taxable income, reversals of existing deferred tax assets and liabilities and ongoing prudent and feasible tax planning strategies, in making such assessment. For the three months ended March 31, 2023 and 2022, the valuation allowance was $<span id="xdx_90E_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230101__20230331_zkBpJrLIQGSg" title="Valuation allowance">692,085</span> and $<span id="xdx_902_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20220331_zmD1o8JfQH41" title="Valuation allowance">0</span>, respectively.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The Company has determined it had no uncertain tax positions as of March 31, 2023. The Company classifies interest and penalties recognized on uncertain tax positions as a component of income tax expense. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 338843 692085 0 <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbGtX6OrWKel" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b><span id="xdx_86E_zk4n4MD1Dv7i">Recent Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p id="xdx_80B_ecustom--InitialPublicOfferingDisclosureTextBlock_zXDMed2K0jK2" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 3 — <span id="xdx_82B_zmoazLqHkPRi">Initial Public Offering</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On December 20, 2021, the Company consummated its IPO of <span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesNewIssuesOne_c20211219__20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pdd" title="Stock issued during period, shares, new issues">10,000,000</span> Units at a purchase price of $<span id="xdx_90D_ecustom--SharesPurchasePricePerShares_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Shares purchase price (in dollars per share)">10.00</span> per Unit. <span id="xdx_909_eus-gaap--SaleOfStockDescriptionOfTransaction_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember" title="Sale of stock, description of transaction">Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant.</span> Each whole warrant entitles the holder to purchase one share of Common Stock at a price of $<span id="xdx_907_ecustom--SaleOfStockPricePerShare1_c20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pdd" title="Stock price per share">11.50</span> per share, subject to adjustment (see Note 7). On December 20, 2021, the underwriters exercised their full over-allotment option and purchased the additional Units available to them. The aggregate Units sold in the IPO and subsequent over-allotment were <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPnEeJ9E2qud" title="Issuance of common stock to sponsors (in shares)">11,500,000</span> and generated gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zrgSxGM1b76j" title="Proceeds from Issuance of Common Stock">115,000,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following the closing of the IPO on December 20, 2021, $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from Issuance of Common Stock">116,725,000</span> from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the Trust Account. This amount was comprised of $<span id="xdx_904_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Share price per unit">10.15</span> per Unit for the <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesNewIssues3_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Stock issued during period new issues">11,500,000</span> Units sold in the IPO. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pp0p0" title="Proceeds from Issuance of Common Stock">116,725,000</span> ($<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z2QytC6vMQ43" title="Share price per unit">10.15</span> per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 10000000 10.00 Each Unit that the Company is offering has a price of $10.00 and consists of one share of Common Stock and three-fourths of one redeemable warrant. 11.50 11500000 115000000 116725000 10.15 11500000 116725000 10.15 <p id="xdx_800_ecustom--PrivatePlacementTextBlock_zZGPDUwf2nck" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 4 — <span id="xdx_826_zv2Vrh6tYk63">Private Placement Warrants</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Issuance of common stock to sponsors (in shares)">6,500,000</span> Private Placement <span id="xdx_90C_eus-gaap--SaleOfStockDescriptionOfTransaction_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember" title="Sale of stock, description of transaction">Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021)</span>, each exercisable to purchase one share of Common Stock at $<span id="xdx_90E_ecustom--SaleOfStockPricePerShare3_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Exercise price per share">11.50</span> per share, at a price of $<span id="xdx_90C_ecustom--SaleOfStockPricePerShare1_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Exercise price per share">1.00</span> per Private Placement Warrant. The sale of the Private Placement Warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgst8jbrqYYe" title="Proceeds from issuance of Private Placement Warrants">7,100,000</span>. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Private Placement Warrants are not transferable, assignable or salable (and the shares of Common Stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination).</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants requires a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 6500000 Warrants (7,100,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 20, 2021) 11.50 1.00 7100000 <p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zhQC8i2A5yai" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 5 — <span id="xdx_822_zAzk20i44xSc">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Founder Shares</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On February 23, 2021, the Company issued the Sponsor an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210222__20210223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares issued for services">2,875,000</span> shares of the Company’s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_c20210223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Common stock, par or stated value per share">0.001</span> per share (the “Founder Shares”) for an aggregate purchase price of $<span id="xdx_90E_ecustom--StockIssuedDuringPeriodValueIssuedForServicesOne_c20210222__20210223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Aggregate purchase price">25,000</span>. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $<span id="xdx_90C_ecustom--CommonStockParOrStatedValuePerShare1_c20210223_pdd" title="Common stock par or stated value per share">12.00</span> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2023 or 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Private Placement Warrants</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Sponsor purchased an aggregate of <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbO7dqMtUMkf" title="Number of stock sold">7,100,000</span> Private Placement Warrants, which includes the <span id="xdx_900_ecustom--UnderwritingFees_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement1Member_pp0p0" title="Underwriting fees">600,000</span> Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Exercise price (in dollars per share)">1.00</span> per warrant, for an aggregate purchase price of $<span id="xdx_908_ecustom--StockIssuedDuringPeriodValueIssuedForServicesOne_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Aggregate purchase price">7,100,000</span>. Each Private Placement Warrant is identical to the Public Warrants, except as described below. <span id="xdx_908_ecustom--BusinessCombinationReasonForBusinessCombinations_c20230101__20230331_zvwSrcVlsYg" title="Business combination, reason for business combinations">There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 40pt"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Administrative Services Agreement</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company’s Sponsor through the earlier of the Company’s consummation of a Business Combination and its liquidation, makes available to the Company certain general and administrative services, including office space, utilities, and administrative services, as the Company may require from time to time. The Company has agreed to pay the Sponsor $<span id="xdx_90F_eus-gaap--SponsorFees_c20230101__20230331__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember_pp0p0" title="Sponsor fees">10,000</span> per month for these services. The Company incurred $<span id="xdx_90B_eus-gaap--AdministrativeFeesExpense_c20230101__20230331__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember_pp0p0" title="Administrative service fees"><span id="xdx_906_eus-gaap--AdministrativeFeesExpense_pp0p0_c20220101__20220331__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember_zxHqVvYE3Ox6" title="Administrative service fees">30,000</span></span> in operating cost associated with the administrative service fees for each of the three months ended March 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 2875000 0.001 25000 12.00 7100000 600000 1.00 7100000 There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within 18 months following the effectiveness of the Public Offering. 10000 30000 30000 <p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zoo9RYdn71n7" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 6 — <span id="xdx_821_zwF0BgfjZ4ok">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In the course of normal operations, the Company may be involved in various claims and litigation that management intends to defend. The range of loss, if any, from potential claims cannot be reasonably estimated. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Initial Business Combination Period Extension</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On December 13, 2022, the <span id="xdx_90F_eus-gaap--BusinessCombinationControlObtainedDescription_c20230101__20230331" title="Business Combination, Control Obtained Description">Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “First Deposit”). The First Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the initial deadline of December 20, 2022, until March 20, 2023. When the Sponsor makes the First Deposit, it will receive 1,150,000 private placement warrants in connection with the First Deposit, however, this deposit has yet to be made.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 15, 2023, the Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “Second Deposit”). The Second Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the first extension deadline of March 20, 2023, until June 20, 2023. When the Sponsor makes the Second Deposit, it will receive 1,150,000 private placement warrants in connection with the Second Deposit, however, this deposit has yet to be made.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Registration and Shareholder Rights</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The holders of the Founder Shares, Public Warrants, and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any shares of Common Stock issuable upon the exercise of the Private Placement Warrants, including those issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares of Common Stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will be effected until after the expiration of the applicable lock-up period, as described herein. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Underwriting Agreement</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 Units to cover over-allotments if any. On December 20, 2021, the underwriters fully exercised the over-allotment option. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The underwriters were paid at the closing of the IPO an underwriting commission of $<span id="xdx_90F_ecustom--UnderwritingCommissionOfUnitSoldInIpo_c20211218__20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pdd" title="Underwriting commission of unit sold (per share)">0.25</span> per Unit sold in the IPO or $<span id="xdx_90D_ecustom--UnderwritingCommissionOfUnitSoldInIpoValue_c20211218__20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Underwriting commission of Unit sold in the IPO Value">2,513,333</span>. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $375,000 for an aggregate of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211218__20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from Issuance of Common Stock">2,888,333</span> in underwriting commissions related to the IPO and over-allotment.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In addition, $<span id="xdx_900_ecustom--DeferredUnderwritingCommissions_c20211220__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_pp0p0" title="Deferred underwriting commisions">3,000,000</span> is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO. Following the exercise of the underwriters’ over-allotment option on December 20, 2021, the underwriters earned an additional $450,000 for an aggregate of $<span id="xdx_90B_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20211220__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__us-gaap--IPOMember_zLKWdubN3HTk" title="Deferred underwriting commisions">3,450,000</span> in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> Company received notice from the Sponsor of the Sponsor’s intention to deposit $1,150,000 into the trust account established in connection with the Company’s initial public offering (the “First Deposit”). The First Deposit is required to extend the period of time the Company will have to consummate its initial business combination by three months from the initial deadline of December 20, 2022, until March 20, 2023. When the Sponsor makes the First Deposit, it will receive 1,150,000 private placement warrants in connection with the First Deposit, however, this deposit has yet to be made. 0.25 2513333 2888333 3000000 3450000 <p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zbm1ebxcasbc" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 7 — <span id="xdx_82B_zmJHLlBRHsRb">Stockholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Preferred Stock</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is authorized to issue <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20230331_zlTK7cMDPbJb" title="Preferred stock, shares authorized"><span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zvLwksTowWce" title="Preferred stock, shares authorized">1,000,000</span></span> preferred shares with a par value of $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230331_zqIPFXZ8I2be" title="Preferred stock, par value"><span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zHGEptUgcvQ2" title="Preferred stock, par value">0.001</span></span> and with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and 2022, there were <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20230331_zIDDFe88SJz9" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zCfHP2R9GVZf" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20230331_zrncD0ySGbQ" title="Preferred stock, shares outstanding"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zBxtNuWYga5e" title="Preferred stock, shares outstanding">no</span></span></span></span> preferred shares issued or outstanding. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; background-color: white"><b>Common Stock</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company is authorized to issue <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20230331_z6cqmiP6XNv5" title="Common stock, shares, authorized"><span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_zkkikcNmUmE2" title="Common stock, shares, authorized">100,000,000</span></span> shares of Common Stock with a par value of $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230331_zLxXL0Tp77f4" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231_zX0r4sBxQcGa" title="Common stock, par value">0.001</span></span> per share. As of March 31, 2023 and 2022, there were <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20230331_zicqVMW1LBZd" title="Common stock, shares, outstanding"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20221231_z4JbTNjQvX5h" title="Common stock, shares, outstanding">2,875,000</span></span> shares of Common Stock outstanding, excluding <span id="xdx_906_ecustom--CommonStockSharesAuthorizedRedemption_iI_c20230331_ziWH57cqesu4" title="Common stock, shares authorized redemption"><span id="xdx_90B_ecustom--CommonStockSharesAuthorizedRedemption_iI_c20221231_z7ZHZf7LhBdf" title="Common stock, shares authorized redemption">11,500,000</span></span> shares of Common Stock subject to possible redemption issued.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Founder Shares</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 23, 2021, the Company issued the Sponsor an aggregate of <span id="xdx_902_eus-gaap--CommonStockSharesIssued_c20210223__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Common stock, shares, issued">2,875,000</span> shares of the Company’s common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeR5uQAWq7qg" title="Common stock, par or stated value per share">0.001</span> per share (the “Founder Shares”) for an aggregate purchase price of $<span id="xdx_90D_eus-gaap--CommonStockValue_iI_pp0p0_c20210223_zHekbl1kR5pe" title="Common stock value">25,000</span>. The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year following the date of the consummation of the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing, all Founder Shares will be released from the lock-up if (1) the last reported sale price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (2) if after a Business Combination there is a transaction whereby all of the Company’s stockholders have the right to exchange their shares for cash, securities or other property. The Sponsor did not transfer, assign or sell any of the Founder shares during the three months ended March 31, 2022 or 2023.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Public Warrants and Private Placement Warrants</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants were issued upon separation of the Units and only whole Public Warrants trade. The Public Warrants will become exercisable on the later of (a) one year after the date that the registration statement for the offering is declared effective by the SEC and (b) the consummation of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExpenseOrRevenueRecognized_c20230101__20230331" title="Class of warrant or right, expense or revenue recognized">The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a registration statement covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is not effective by the 60th business day following the consummation of the Company’s initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.4pt"/><td style="width: 18pt">•</td><td style="text-align: justify">in whole and not in part;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.4pt"/><td style="width: 18pt">•</td><td style="text-align: justify">at a price of $0.01 per warrant;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.4pt"/><td style="width: 18pt">•</td><td style="text-align: justify">upon not less than 30 days prior written notice of redemption given after the warrants become exercisable (the “30-day redemption period”) to each warrant holder; and</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 22.4pt"/><td style="width: 18pt">•</td><td style="text-align: justify">if, and only if, the reported last sale price of the Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three days before the Company sends the notice of redemption to the warrant holders.</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Common Stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of Common Stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares of Common Stock under the blue sky laws of the state of residence in those states in which the warrants were offered by the Company in the Public Offering.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company calls the warrants for redemption as described above, the Company’s management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” the Company’s management will consider, among other factors, its cash position, the number of outstanding warrants and the dilutive effect on the Company’s stockholders of issuing the maximum number of shares of Common Stock issuable upon the exercise of the Company’s warrants. In such an event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” for this purpose shall mean the average reported last sale price of the Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sponsor purchased an aggregate of <span id="xdx_900_ecustom--UnderwritingFees_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Underwriting fees">7,100,000</span> Private Placement Warrants, which includes the <span id="xdx_904_ecustom--UnderwritingFees_pp0p0_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacement1Member_zxl5TMjfke18" title="Underwriting fees">600,000</span> Private Placement Warrants purchased by the Sponsor to account for the underwriters’ exercise of the over-allotment option, at a price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zQ0gxYH3WKI1" title="Exercise price (in dollars per share)">1.00</span> per warrant, for an aggregate purchase price of $<span id="xdx_908_ecustom--UnderwritingFees_pp0p0_c20230101__20230331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zOO1xvWq0Ns5" title="Underwriting fees">7,100,000</span>. Each Private Placement Warrant is identical to the Public Warrants except as described below. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Warrants or placement rights, which will expire worthless if the Company does not consummate a Business Combination within <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtM_c20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--RangeAxis__srt--MinimumMember_z58IS3b0kJbk" title="Warrant terms">18</span> months following the effectiveness of the Public Offering. The Company’s initial stockholders have agreed to waive their redemption rights with respect to any Founder Shares or Private Placement Warrants (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend its amended and restated certificate of incorporation to modify the substance or timing of its obligation to allow redemption in connection with the Company’s initial Business Combination or certain amendments to its charter prior thereto, to redeem 100% of the Company’s Public Shares if the Company does not consummate its initial Business Combination within 18 months following the effectiveness of the Public Offering or with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) if the Company fails to consummate a Business Combination within 18 months following the effectiveness of the Public Offering or if the Company liquidates prior to the expiration of the 18-month period. However, the Company’s initial stockholders will be entitled to redemption rights with respect to any Public Shares held by them if the Company fails to consummate a Business Combination or liquidate within the 18-month period. </p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All warrants meet the requirements for equity classification and the Company accounts for the warrants as equity instruments in accordance with ASC 815, "Derivatives and Hedging", effective with the Public Offering.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> 1000000 1000000 0.001 0.001 0 0 0 0 100000000 100000000 0.001 0.001 2875000 2875000 11500000 11500000 2875000 0.001 25000 The Public Warrants have an exercise price of $11.50 per share, subject to adjustment as described herein. In addition, if (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the consummation of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Common Stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. 7100000 600000 1.00 7100000 P18M <p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zRBb9cPhloH8" style="font: 10pt Times New Roman; margin: 0pt 0"><span style="background-color: white"><b>Note 8 </b></span><b>— <span style="background-color: white"><span id="xdx_82C_zK0MXD7Q3CT5">Fair Value Measurements</span></span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Fair value is defined as the price that would be received for the sale of an asset or paid for the transfer of a liability, in an orderly transaction between market participants at the measurement date. </span>U.S. <span style="background-color: white">GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.6pt"/><td style="width: 13.4pt">●</td><td style="text-align: justify">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.6pt"/><td style="width: 13.4pt">●</td><td style="text-align: justify">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 31.6pt"/><td style="width: 13.4pt">●</td><td style="text-align: justify">Level 3, is defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</td></tr></table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zaFQWuX90R76" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BC_z2jv90RBfba9" style="display: none">Schedule of fair value on a recurring basis</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2023</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 27pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20230331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0601">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0607">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 27pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zTHGp2SbZkU5" style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">There were no transfers between Levels 1, 2 or 3 for the period from Inception through </span>March 31, 2023.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zaFQWuX90R76" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"><span id="xdx_8BC_z2jv90RBfba9" style="display: none">Schedule of fair value on a recurring basis</span></td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">March 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2023</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 27pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20230331_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">119,254,187</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20230331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0601">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Quoted</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Prices In</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Active</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Markets</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Observable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Significant</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Other</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Unobservable</b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: center"><b>Inputs</b></p></td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">2022</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 1)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 2)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">(Level 3)</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Description</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap">Assets:</td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-bottom: 1pt">U.S. Money Market Funds held in Trust Account</td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 18pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0607">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1pt solid; padding-left: 27pt; width: 12%; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets">118,193,123</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl0617">-</span></td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 119254187 119254187 119254187 119254187 118193123 118193123 118193123 118193123 <p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zEXBieUiPOpi" style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify"><b>Note 9 — <span id="xdx_82B_za9o1LuAwI0l">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company evaluated subsequent events and transactions that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</p> Remeasurement adjustment is net of amounts eligible to be withdrawn from the Trust Account to pay franchise and income taxes for the period. EXCEL 39 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 41 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 71 162 1 true 21 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://adrt.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited) Sheet http://adrt.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://adrt.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://adrt.com/role/UnauditedCondensedStatementsOfOperations UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Business Operations Sheet http://adrt.com/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Initial Public Offering Sheet http://adrt.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 00000010 - Disclosure - Private Placement Warrants Sheet http://adrt.com/role/PrivatePlacementWarrants Private Placement Warrants Notes 10 false false R11.htm 00000011 - Disclosure - Related Party Transactions Sheet http://adrt.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 00000012 - Disclosure - Commitments and Contingencies Sheet http://adrt.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders??? Equity Sheet http://adrt.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 00000014 - Disclosure - Fair Value Measurements Sheet http://adrt.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://adrt.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - Fair Value Measurements (Tables) Sheet http://adrt.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://adrt.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - Organization and Business Operations (Details Narrative) Sheet http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative Organization and Business Operations (Details Narrative) Details http://adrt.com/role/OrganizationAndBusinessOperations 19 false false R20.htm 00000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1) Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1 Basis of Presentation and Summary of Significant Accounting Policies (Details 1) Details http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 00000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Sheet http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Details http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - Initial Public Offering (Details Narrative) Sheet http://adrt.com/role/InitialPublicOfferingDetailsNarrative Initial Public Offering (Details Narrative) Details http://adrt.com/role/InitialPublicOffering 23 false false R24.htm 00000024 - Disclosure - Private Placement Warrants (Details Narrative) Sheet http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative Private Placement Warrants (Details Narrative) Details http://adrt.com/role/PrivatePlacementWarrants 24 false false R25.htm 00000025 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://adrt.com/role/RelatedPartyTransactions 25 false false R26.htm 00000026 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://adrt.com/role/CommitmentsAndContingencies 26 false false R27.htm 00000027 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://adrt.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://adrt.com/role/StockholdersEquity 27 false false R28.htm 00000028 - Disclosure - Fair Value Measurements (Details) Sheet http://adrt.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://adrt.com/role/FairValueMeasurementsTables 28 false false All Reports Book All Reports g5523010q.htm adrt-20230331.xsd adrt-20230331_cal.xml adrt-20230331_def.xml adrt-20230331_lab.xml adrt-20230331_pre.xml ex31_1.htm ex31_2.htm ex32_1.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 44 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g5523010q.htm": { "axisCustom": 1, "axisStandard": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 210, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 71, "dts": { "calculationLink": { "local": [ "adrt-20230331_cal.xml" ] }, "definitionLink": { "local": [ "adrt-20230331_def.xml" ] }, "inline": { "local": [ "g5523010q.htm" ] }, "labelLink": { "local": [ "adrt-20230331_lab.xml" ] }, "presentationLink": { "local": [ "adrt-20230331_pre.xml" ] }, "schema": { "local": [ "adrt-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 266, "entityCount": 1, "hidden": { "http://adrt.com/20230331": 7, "http://fasb.org/us-gaap/2023": 26, "http://xbrl.sec.gov/dei/2023": 5, "total": 38 }, "keyCustom": 51, "keyStandard": 111, "memberCustom": 8, "memberStandard": 12, "nsprefix": "adrt", "nsuri": "http://adrt.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://adrt.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Private Placement Warrants", "menuCat": "Notes", "order": "10", "role": "http://adrt.com/role/PrivatePlacementWarrants", "shortName": "Private Placement Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "11", "role": "http://adrt.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "12", "role": "http://adrt.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "13", "role": "http://adrt.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "14", "role": "http://adrt.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "15", "role": "http://adrt.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "16", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:RedeemableSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "17", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:RedeemableSharesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "18", "role": "http://adrt.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:DeferredUnderwritingCommissions", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Organization and Business Operations (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "shortName": "Organization and Business Operations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrust", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONDENSED BALANCE SHEETS (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://adrt.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "adrt:RedeemableSharesTableTextBlock", "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:ProceedsFromIssuanceOfCommonStock1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "20", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "adrt:RedeemableSharesTableTextBlock", "adrt:AccountingPolicyOnRedeemableSharesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "adrt:ProceedsFromIssuanceOfCommonStock1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_CommonStockSubjectToMandatoryRedemptionMember", "decimals": "0", "first": true, "lang": null, "name": "adrt:AllocationOfNetIncomeAsAdjusted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details 1)", "menuCat": "Details", "order": "21", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_CommonStockSubjectToMandatoryRedemptionMember", "decimals": "0", "first": true, "lang": null, "name": "adrt:AllocationOfNetIncomeAsAdjusted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "adrt:InitialPublicOfferingDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2021-12-192021-12-20_us-gaap_IPOMember502361421", "decimals": "INF", "first": true, "lang": null, "name": "adrt:SharesPurchasePricePerShares", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Initial Public Offering (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "shortName": "Initial Public Offering (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "adrt:InitialPublicOfferingDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2021-12-192021-12-20_us-gaap_IPOMember502361421", "decimals": "INF", "first": true, "lang": null, "name": "adrt:SharesPurchasePricePerShares", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "adrt:PrivatePlacementTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2021-12-182021-12-20_us-gaap_PrivatePlacementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Private Placement Warrants (Details Narrative)", "menuCat": "Details", "order": "24", "role": "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative", "shortName": "Private Placement Warrants (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "adrt:PrivatePlacementTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2021-12-20_us-gaap_PrivatePlacementMember", "decimals": "INF", "lang": null, "name": "adrt:SaleOfStockPricePerShare3", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Related Party Transactions (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2021-02-23", "decimals": "INF", "lang": null, "name": "adrt:CommonStockParOrStatedValuePerShare1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationControlObtainedDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "26", "role": "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationControlObtainedDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://adrt.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2021-02-23", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Fair Value Measurements (Details)", "menuCat": "Details", "order": "28", "role": "http://adrt.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "adrt:CommonStockSharesAuthorizedRedemption", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DirectOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfOperations", "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DirectOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "0", "lang": null, "name": "adrt:IncomeFromInvestments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization and Business Operations", "menuCat": "Notes", "order": "7", "role": "http://adrt.com/role/OrganizationAndBusinessOperations", "shortName": "Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Initial Public Offering", "menuCat": "Notes", "order": "9", "role": "http://adrt.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "g5523010q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "adrt:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 21, "tag": { "adrt_AccountingPolicyOnRedeemableSharesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policy on Redeemable Shares" } } }, "localname": "AccountingPolicyOnRedeemableSharesPolicyTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_AccretionOfCarryingValueToRedemptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents accretion of carrying value to redemption value.", "label": "Remeasurement of carrying value to redemption value" } } }, "localname": "AccretionOfCarryingValueToRedemptionValue", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_AccretionOfCarryingValueToRedemptionValueOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents accretion of carrying value to redemption value one.", "label": "Accretion of Carrying Value to Redemption Value One", "verboseLabel": "Remeasurement of common stock subject to possible redemption" } } }, "localname": "AccretionOfCarryingValueToRedemptionValueOne", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_AccruedFranchiseTaxes": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued franchise taxes" } } }, "localname": "AccruedFranchiseTaxes", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_AdditionalTransactionCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Additional transaction cost" } } }, "localname": "AdditionalTransactionCost", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_AdministrativeServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Administrative Services Agreement [Member]" } } }, "localname": "AdministrativeServicesAgreementMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_AggregateUnitsSoldInIpo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents aggregate units sold in ipo.", "label": "Aggregate units sold in the IPO" } } }, "localname": "AggregateUnitsSoldInIpo", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_AllocationOfNetIncomeAsAdjusted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allocation of net income as adjusted.", "label": "Allocation of net loss" } } }, "localname": "AllocationOfNetIncomeAsAdjusted", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "adrt_BasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockSubjectToRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net income (loss) per share attributable to common stockholders" } } }, "localname": "BasicAndDilutedNetIncomeLossPerShareAttributableToCommonStockSubjectToRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "adrt_BasicAndDilutedNetIncomePerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net loss per common share" } } }, "localname": "BasicAndDilutedNetIncomePerCommonShare", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "perShareItemType" }, "adrt_BasicAndDilutedWeightedAverageSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding" } } }, "localname": "BasicAndDilutedWeightedAverageSharesOutstanding", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "sharesItemType" }, "adrt_BusinessCombinationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination [Axis]", "verboseLabel": "BusinessCombinationAxis [Axis]" } } }, "localname": "BusinessCombinationAxis", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "adrt_BusinessCombinationDomain": { "auth_ref": [], "localname": "BusinessCombinationDomain", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_BusinessCombinationReasonForBusinessCombinations": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business combination, reason for business combinations" } } }, "localname": "BusinessCombinationReasonForBusinessCombinations", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "adrt_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents class of warrant or right exercise price of warrants or rights11.", "label": "Share price per unit" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights11", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_CommonStock0.001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.001 par value" } } }, "localname": "CommonStock0.001ParValueMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "adrt_CommonStockParOrStatedValuePerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents common stock par or stated value per share1.", "label": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare1", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_CommonStockSharesAuthorizedRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents common stock shares authorized redemption.", "label": "Common stock, shares authorized redemption" } } }, "localname": "CommonStockSharesAuthorizedRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_CommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents common stock subject to possible redemption.", "label": "Remeasurement adjustment on redeemable common stock, net" } } }, "localname": "CommonStockSubjectToPossibleRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "adrt_CommonStockSubjectToPossibleRedemption1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents common stock subject to possible redemption1.", "label": "Common Stock Subject to Possible Redemption1", "periodEndLabel": "Common stock subject to possible redemption", "periodStartLabel": "Common stock subject to possible redemption" } } }, "localname": "CommonStockSubjectToPossibleRedemption1", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_CommonStockValueRedemption": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock subject to possible redemption, 11,500,000 shares at redemption value(1)" } } }, "localname": "CommonStockValueRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_DeferredUnderwritingCommissions": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents deferred underwriting commissions.", "label": "Deferred underwriting commissions", "verboseLabel": "Deferred underwriting commisions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/CondensedBalanceSheets", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_DisclosureInitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering" } } }, "localname": "DisclosureInitialPublicOfferingAbstract", "nsuri": "http://adrt.com/20230331", "xbrltype": "stringItemType" }, "adrt_DisclosurePrivatePlacementWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants" } } }, "localname": "DisclosurePrivatePlacementWarrantsAbstract", "nsuri": "http://adrt.com/20230331", "xbrltype": "stringItemType" }, "adrt_EmergingGrowthCompanyStatusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyStatusPolicyTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_GrossProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents gross proceeds.", "label": "Gross proceeds" } } }, "localname": "GrossProceeds", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_IncomeFromInvestments": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncomeFromInvestments", "negatedLabel": "Income from investments held in Trust Account" } } }, "localname": "IncomeFromInvestments", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_IncomeFromInvestmentsHeldInTrustAccount": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income from investments held in trust account" } } }, "localname": "IncomeFromInvestmentsHeldInTrustAccount", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "adrt_InitialPublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InitialPublicOfferingDisclosureTextBlock", "verboseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingDisclosureTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "adrt_InvestmentOfCashInTrustAccount": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "InvestmentOfCashInTrustAccount", "negatedLabel": "Sale of investment held in Trust Account" } } }, "localname": "InvestmentOfCashInTrustAccount", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_IssuanceCostsAllocatedToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents issuance costs allocated to common stock.", "label": "Issuance costs allocated to common stock" } } }, "localname": "IssuanceCostsAllocatedToCommonStock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_LiquidationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidation [Member]" } } }, "localname": "LiquidationMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_NonRedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Redeemable Common Stock [Member]" } } }, "localname": "NonRedeemableCommonStockMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "adrt_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offering Costs Associated with the Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_PaymentOfOfferingCosts": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentOfOfferingCosts", "negatedLabel": "Payments of offering costs" } } }, "localname": "PaymentOfOfferingCosts", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_PrepaidAssetsNoncurrentPortion": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid expenses, noncurrent" } } }, "localname": "PrepaidAssetsNoncurrentPortion", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "adrt_PrivatePlacement1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement 1 [Member]" } } }, "localname": "PrivatePlacement1Member", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PrivatePlacementTextBlock", "verboseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/PrivatePlacementWarrants" ], "xbrltype": "textBlockItemType" }, "adrt_ProceedsAllocatedToPrivatePlacementWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents proceeds allocated to private placement warrants.", "label": "Proceeds allocated to Public Warrants" } } }, "localname": "ProceedsAllocatedToPrivatePlacementWarrants", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_ProceedsFromIssuanceOfCommonStock1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents proceeds from issuance of common stock.", "label": "Proceeds From Issuance of Common Stock1", "verboseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfCommonStock1", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "adrt_RedeemableSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of common stock subject to possible redemption" } } }, "localname": "RedeemableSharesTableTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "adrt_RemeasurementOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Remeasurement of common stock subject to possible redemption" } } }, "localname": "RemeasurementOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_SaleOfStockDescriptionOfTransaction1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents sale of stock description of transaction.", "label": "Description of stock issuance" } } }, "localname": "SaleOfStockDescriptionOfTransaction1", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "adrt_SaleOfStockPricePerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents sale of stock price per share1.", "label": "Stock price per share", "verboseLabel": "Exercise price per share" } } }, "localname": "SaleOfStockPricePerShare1", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SaleOfStockPricePerShare3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents sale of stock price per share3.", "label": "Exercise price per share" } } }, "localname": "SaleOfStockPricePerShare3", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SharesPurchasePricePerShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents shares purchase price per shares.", "label": "Shares purchase price (in dollars per share)" } } }, "localname": "SharesPurchasePricePerShares", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssues2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents stock issued during period shares new issues.", "label": "New issue of shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues2", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssues3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents stock issued during period shares new issues3.", "label": "Stock issued during period new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues3", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_StockIssuedDuringPeriodSharesNewIssuesOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents stock issued during period shares new issues one.", "label": "Stock issued during period, shares, new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssuesOne", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative" ], "xbrltype": "sharesItemType" }, "adrt_StockIssuedDuringPeriodValueIssuedForServicesOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents stock issued during period value issued for services one.", "label": "Aggregate purchase price" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServicesOne", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_SupplementalDisclosureOfNoncashInvestingAndFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of noncash investing and financing activities:" } } }, "localname": "SupplementalDisclosureOfNoncashInvestingAndFinancingActivitiesAbstract", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "adrt_TaxesPayable": { "auth_ref": [], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Tax payable" } } }, "localname": "TaxesPayable", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "adrt_UnderwritingCommission": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents underwriting commissions.", "label": "UnderwritingCommission", "verboseLabel": "Underwriting commissions" } } }, "localname": "UnderwritingCommission", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_UnderwritingCommissionOfUnitSoldInIpo": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The element represents underwriting commission of unit sold in ipo.", "label": "Underwriting commission of unit sold (per share)" } } }, "localname": "UnderwritingCommissionOfUnitSoldInIpo", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "adrt_UnderwritingCommissionOfUnitSoldInIpoValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents underwriting commission of unit sold in ipo value.", "label": "Underwriting commission of Unit sold in the IPO Value" } } }, "localname": "UnderwritingCommissionOfUnitSoldInIpoValue", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_UnderwritingCommissions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents underwriting commissions.", "label": "Underwriting commissions" } } }, "localname": "UnderwritingCommissions", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The element represents underwriting fees.", "label": "Underwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "adrt_UnitsEachConsistingOfOneShareOfcommonStockParValue0.001PerShareandThreefourthsOfOneRedeemableWarrantToPurchaseOneShareOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Units, each consisting of one share of\u00a0Common Stock, par value $0.001 per share\u00a0and three-fourths of one Redeemable Warrant to purchase one share of Common Stock" } } }, "localname": "UnitsEachConsistingOfOneShareOfcommonStockParValue0.001PerShareandThreefourthsOfOneRedeemableWarrantToPurchaseOneShareOfCommonStockMember", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "adrt_WarrantInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Instruments" } } }, "localname": "WarrantInstrumentsPolicyTextBlock", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "adrt_WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding, common stock" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedOne", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "adrt_WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average shares outstanding, common stock subject to redemption" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDilutedRedemption", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "adrt_WorkingCapitalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The element represents working capital amount.", "label": "Working capital amount" } } }, "localname": "WorkingCapitalAmount", "nsuri": "http://adrt.com/20230331", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r382", "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r377" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity common stock, shares outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://adrt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MinimumMember": { "auth_ref": [ "r120", "r121", "r122", "r123", "r158", "r215", "r239", "r269", "r270", "r331", "r332", "r333", "r334", "r335", "r345", "r346", "r350", "r353", "r357", "r359", "r406", "r415", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r120", "r121", "r122", "r123", "r150", "r158", "r159", "r160", "r161", "r214", "r215", "r239", "r269", "r270", "r331", "r332", "r333", "r334", "r335", "r345", "r346", "r350", "r353", "r357", "r359", "r362", "r402", "r406", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r120", "r121", "r122", "r123", "r150", "r158", "r159", "r160", "r161", "r214", "r215", "r239", "r269", "r270", "r331", "r332", "r333", "r334", "r335", "r345", "r346", "r350", "r353", "r357", "r359", "r362", "r402", "r406", "r416", "r417", "r418", "r419", "r420" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r9", "r358" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r80", "r81", "r196", "r197", "r198", "r199", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r80", "r81", "r196", "r197", "r198", "r199", "r200", "r201" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r31", "r358", "r423" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r162", "r163", "r164", "r256", "r396", "r397", "r398", "r409", "r425" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r25", "r298", "r424" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.", "label": "Administrative service fees" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r50", "r72", "r87", "r108", "r111", "r113", "r115", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r178", "r180", "r195", "r230", "r291", "r358", "r370", "r404", "r405", "r413" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r69", "r76", "r87", "r115", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r178", "r180", "r195", "r358", "r404", "r405", "r413" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r393" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Cash held from out side" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustCurrent": { "auth_ref": [ "r393" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Cash and marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r393" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Asset, Held-in-Trust, Noncurrent" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Transaction cost", "verboseLabel": "Deferred underwriting commisions" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationControlObtainedDescription": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "This element represents a description of how the entity obtained control of the acquired entity.", "label": "Business Combination, Control Obtained Description" } } }, "localname": "BusinessCombinationControlObtainedDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r57", "r231", "r267", "r286", "r358", "r370", "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r14", "r71", "r347" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r14", "r41", "r84" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r1", "r41" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r392", "r421" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Current asset - cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r66", "r73", "r74", "r75", "r87", "r100", "r101", "r103", "r104", "r106", "r107", "r115", "r124", "r126", "r127", "r128", "r131", "r132", "r135", "r136", "r138", "r141", "r147", "r195", "r247", "r248", "r249", "r250", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r268", "r278", "r300", "r323", "r338", "r339", "r340", "r341", "r342", "r391", "r394", "r399" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://adrt.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightExpenseOrRevenueRecognized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expense or revenue offset related to the warrants or rights.", "label": "Class of warrant or right, expense or revenue recognized" } } }, "localname": "ClassOfWarrantOrRightExpenseOrRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r46", "r118", "r119", "r344", "r403" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r396", "r397", "r409", "r422", "r425" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in dollars per share)", "verboseLabel": "Common stock, par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r30", "r278" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock, shares, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r30", "r278", "r297", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock, shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSubjectToMandatoryRedemptionMember": { "auth_ref": [ "r4", "r6" ], "lang": { "en-us": { "role": { "documentation": "Shares that embody an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur, that represent equity ownership in a corporation, provide voting rights, entitle the holder to a share of the company's success through dividends and/or capital appreciation and, in the event of liquidation, provide rights to a company's assets only after bondholders, other debt holders, and preferred stockholders have been satisfied.", "label": "Common Stock Subject to Mandatory Redemption [Member]" } } }, "localname": "CommonStockSubjectToMandatoryRedemptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r30", "r233", "r358" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding", "verboseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r28", "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r167", "r168" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax asset, noncurrent" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r38" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Operating costs" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r55", "r255", "r301", "r336", "r337", "r368", "r369", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend Income, Operating" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r16", "r17" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Income (Loss) per Share of Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r7", "r67", "r80", "r81", "r82", "r88", "r89", "r90", "r92", "r97", "r99", "r105", "r116", "r117", "r149", "r162", "r163", "r164", "r174", "r175", "r182", "r183", "r184", "r185", "r186", "r187", "r189", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r240", "r241", "r242", "r256", "r323" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r192", "r193", "r194" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r192", "r193", "r194" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Schedule of fair value on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r133", "r151", "r152", "r153", "r154", "r155", "r156", "r193", "r211", "r212", "r213", "r351", "r352", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r133", "r151", "r156", "r193", "r211", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r133", "r151", "r156", "r193", "r212", "r351", "r352", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r133", "r151", "r152", "r153", "r154", "r155", "r156", "r193", "r213", "r351", "r352", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r133", "r151", "r152", "r153", "r154", "r155", "r156", "r211", "r212", "r213", "r351", "r352", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r36", "r52", "r108", "r110", "r112", "r114", "r229", "r236", "r349" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Net income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r56", "r64", "r98", "r99", "r109", "r169", "r176", "r238" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r79", "r165", "r166", "r170", "r171", "r172", "r173", "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r408" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r3" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r3" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in current assets and current liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r3" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r54" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r11", "r87", "r115", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r179", "r180", "r181", "r195", "r277", "r348", "r370", "r404", "r413", "r414" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r35", "r51", "r235", "r358", "r395", "r401", "r411" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r12", "r70", "r87", "r115", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r179", "r180", "r181", "r195", "r358", "r404", "r413", "r414" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r58", "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Organization and Business Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/OrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r83" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r83" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r41", "r42", "r43" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r37", "r43", "r53", "r68", "r77", "r78", "r82", "r87", "r91", "r93", "r94", "r95", "r96", "r98", "r99", "r102", "r108", "r110", "r112", "r114", "r115", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r190", "r195", "r237", "r299", "r321", "r322", "r349", "r369", "r404" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net income (loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfCashFlows", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit", "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r108", "r110", "r112", "r114", "r349" ], "calculation": { "http://adrt.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherOwnershipInterestsOfferingCosts": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of offering costs allocated to the other unit holders.", "label": "Other offering costs" } } }, "localname": "OtherOwnershipInterestsOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r29", "r135" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value (in dollars per share)", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r29", "r278" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r29", "r135" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r29", "r278", "r297", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheetsParenthetical", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r29", "r232", "r358" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r2" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Option exercise generated gross proceeds", "terseLabel": "Proceeds from issuance of Private Placement Warrants", "verboseLabel": "Proceeds from Issuance of Common Stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r157", "r206", "r207", "r272", "r273", "r274", "r275", "r276", "r296", "r298", "r330" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r206", "r207", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r304", "r305", "r308" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r157", "r206", "r207", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r272", "r273", "r274", "r275", "r276", "r296", "r298", "r330", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r203", "r204", "r205", "r207", "r208", "r252", "r253", "r254", "r306", "r307", "r308", "r327", "r329" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r32", "r48", "r234", "r243", "r244", "r251", "r279", "r358" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r67", "r88", "r89", "r90", "r92", "r97", "r99", "r116", "r117", "r162", "r163", "r164", "r174", "r175", "r182", "r184", "r185", "r187", "r189", "r240", "r242", "r256", "r425" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r5", "r23", "r49" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of stock, description of transaction" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Number of stock sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of stock, price per share", "verboseLabel": "Share price per unit" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of reflects the calculation of basic and diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r25", "r26", "r304", "r305", "r308" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, end (in shares)", "periodStartLabel": "Balance at beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r44", "r85" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SponsorFees": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.", "label": "Sponsor fees" } } }, "localname": "SponsorFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r66", "r73", "r74", "r75", "r87", "r100", "r101", "r103", "r104", "r106", "r107", "r115", "r124", "r126", "r127", "r128", "r131", "r132", "r135", "r136", "r138", "r141", "r147", "r195", "r247", "r248", "r249", "r250", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r268", "r278", "r300", "r323", "r338", "r339", "r340", "r341", "r342", "r391", "r394", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://adrt.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r7", "r13", "r67", "r80", "r81", "r82", "r88", "r89", "r90", "r92", "r97", "r99", "r105", "r116", "r117", "r149", "r162", "r163", "r164", "r174", "r175", "r182", "r183", "r184", "r185", "r186", "r187", "r189", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r240", "r241", "r242", "r256", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r88", "r89", "r90", "r105", "r216", "r245", "r268", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r281", "r282", "r283", "r284", "r285", "r287", "r288", "r289", "r290", "r292", "r293", "r294", "r295", "r296", "r298", "r302", "r303", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r323", "r363" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://adrt.com/role/Cover", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r105", "r216", "r245", "r268", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r281", "r282", "r283", "r284", "r285", "r287", "r288", "r289", "r290", "r292", "r293", "r294", "r295", "r296", "r298", "r302", "r303", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r323", "r363" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails1", "http://adrt.com/role/Cover", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for services" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r7", "r29", "r30", "r48", "r247", "r323", "r339" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock to Sponsors (in shares)", "verboseLabel": "Issuance of common stock to sponsors (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r30", "r33", "r34", "r45", "r280", "r297", "r324", "r325", "r358", "r370", "r395", "r401", "r411", "r425" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets", "http://adrt.com/role/UnauditedCondensedStatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r47", "r86", "r134", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r149", "r188", "r326", "r328", "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r209", "r210" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative", "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative", "http://adrt.com/role/RelatedPartyTransactionsDetailsNarrative", "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/PrivatePlacementWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r10" ], "calculation": { "http://adrt.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Income tax payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://adrt.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://adrt.com/role/InitialPublicOfferingDetailsNarrative", "http://adrt.com/role/OrganizationAndBusinessOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r18", "r19", "r20", "r59", "r60", "r62", "r63" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant terms" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://adrt.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "39", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r371": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r372": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r373": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r374": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r375": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r376": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r377": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r378": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r379": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r381": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r382": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r383": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r384": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r385": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r386": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r387": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r388": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r389": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 45 0001214659-23-007724-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-23-007724-xbrl.zip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
VU]TE#D9A]W[7*M6KEK!,.Z4TM[(4HI/Q3\3E PQP_L4K[*9EL1 M3O6/AI4HG*(E."KQ!RS^[/6<.FBM_>:BO: F5FSD&.6H#<943H8LS?@6 M]%_LFG8^RES.#X$4>6;"1_*7ZUSGTC9[9]O5PC)570DS/XZE9_#K&]O,TC_)X M!V.[L2 3':HJ .C#:5 ']OMT&UC>UN"A[&=+O7$&#*_O\=$$ZC/*.EM+#=# M;<=PM1BHL=L(4=I+%L(E&[>+6AY(V#[W'K!U%X)JV[:S::]BE-;CMJZ^[UM+ M!FB$9G5D_V?.SX]T0DS[UC6=1Y TIGV6/9CER?"'GN05]_ =[X:>/ MFPQ0?]4JYJ!W&Y-.5ZL%1J("@1RN_[^B)<"K3D'JKR8FNT+E3,DM%M0WZ]4J MX]=JHHP!S0IVB71^SV+,\6W:9LLK3]SWA'9:LK<%^VX_1;O WTVQP;>1=E\7 M:;>_5SA*VM)9-\A%^?TM5-H_5,NU?6T\#>Y7S^\WOUF_84'>>L%6%6U)OU$I M,#B^#73SK7Q*9%U4L%5=(J1DUW/R$.7I/_EP=4I'K")+$_X/VKNOZ"=G'97] M-_91VVD/ N]L@_0H'0^(/3+ M9[VM?4.7&HXL.G=26N$O2ZP:P%.MA(EJ3 L%(+S40QSJGWZS+-<5FB M3C4X;VJW!SKSN:(=(':XYFE0\'I9TPI\<.52*PV&5U:(&M]V-FEM-"!9I)OT M(4_OTSC**[EJM_BY>D_?^T7S,5R5O4;/F%2A01P-)TTP3)P$5Q6$D)_8#D90 M9OYNULME1%[8L]X;D(+&>UIX=@_.JTZ/4]2-T4H]\PV M 1V6:1VN*Y(^TM7(51;%?$GR2T1(I%\R3]8.8,UWXZ*\_(%%.<(*>1RGYF>4LZ&IC M6V*;57S2T 5\GWDF>3!D

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end